Browse by Title

Type here to filter the list

A
A Global Perspective of Roles, Responsibilities and Impact of Transfusion Safety Officers (AM24-TU-08-L)
Favorite

Suzanne Thibodeaux, MD, PhD, CABP(H) (she/her/hers) – Washington University School of Medicine ### 833164###Program Chair###Associate Professor###Washington University School of Medicine###
Program Chair: Suzanne Thibodeaux, MD, PhD, CABP(H) (she/her/hers) – Washington University School of Medicine
### she/her/hers @@@ Asawari Bapat, MD, PGDHHM, CABP(H), DABRM, FABRM. (she/her/hers) – Global Regenerative Medicine Consultant ### 2362176###Speaker###Consultant###Global Regenerative Medicine Consultant###
Speaker: Asawari Bapat, MD, PGDHHM, CABP(H), DABRM, FABRM. (she/her/hers) – Global Regenerative Medicine Consultant
### she/her/hers @@@ Richard Schäfer, MD – Medical Center University of Freiburg ### 2362188###Speaker###Medical Director, Transfusion Services###Medical Center University of Freiburg###
Speaker: Richard Schäfer, MD – Medical Center University of Freiburg
### @@@ Nour Al-Mozain, MD, CABP, QIA – King Faisal Specialist Hospital & Research center-Riyadh ### 2418615###Speaker######King Faisal Specialist Hospital & Research center-Riyadh###
Speaker: Nour Al-Mozain, MD, CABP, QIA – King Faisal Specialist Hospital & Research center-Riyadh
### AM24-TU-08-L
A Haemovigilance Perspective on Routine HEV-RNA NAT Testing in Swiss Donors (OA1-AM24-ST-06)
Favorite

Soraya Amar El-Dusouqui, MD, CMO (she/her/hers) – Swiss Transfusion SRC ### 2418192###Presenting Author######Swiss Transfusion SRC###
Presenting Author: Soraya Amar El-Dusouqui, MD, CMO (she/her/hers) – Swiss Transfusion SRC
### she/her/hers OA1-AM24-ST-06
A Model to Improve Transfusion Quality Systems Worldwide: AABB (Association for the Advancement of Blood and Biotherapies -AMMTAC (Mexican Association of Transfusion Medicine, AC) International Partnership Chronicles (AM24-TU-05-L)
Favorite

Christine A. Bales, BS, MLS, I (ASCP) CQA (ASQ) (she/her/hers) – AABB ### 832406###Program Chair###Vice President, Global Impact###AABB###
Program Chair: Christine A. Bales, BS, MLS, I (ASCP) CQA (ASQ) (she/her/hers) – AABB
### she/her/hers @@@ Celina Montemayor-Garcia, MD, PhD (she/her/hers) – Canadian Blood Services ### 837540###Speaker###Medical and Scientific Lead, Red Cell Genomics###Canadian Blood Services###
Speaker: Celina Montemayor-Garcia, MD, PhD (she/her/hers) – Canadian Blood Services
### she/her/hers @@@ Maria Isabel Castro Pérez, MC. (she/her/hers) – AMMTAC (Mexican Society of Transfusion Medicine, AC ### 2362172###Speaker###President###AMMTAC (Mexican Society of Transfusion Medicine, AC###
Speaker: Maria Isabel Castro Pérez, MC. (she/her/hers) – AMMTAC (Mexican Society of Transfusion Medicine, AC
### she/her/hers @@@ Emmanuel Fernandez, MD (he/him/his) – National Institute of Pediatrics ### 2411778###Speaker###Head of Department of Blood Bank###National Institute of Pediatrics###
Speaker: Emmanuel Fernandez, MD (he/him/his) – National Institute of Pediatrics
### he/him/his AM24-TU-05-L
A Multidisciplinary Approach to Delivering Comprehensive Care for Chronically Transfused Children and Adults with Sickle Cell Disease: An Overview of the Vanderbilt Sickle Cell Pathways Experience (AM24-MN-02-L)
Favorite

Deva Sharma, MD (she/her/hers) – Vanderbilt University Medical Center ### 2118874###Program Chair###Physician (Hematology & Transfusion Medicine)###Vanderbilt University Medical Center###
Program Chair: Deva Sharma, MD (she/her/hers) – Vanderbilt University Medical Center
### she/her/hers @@@ Deva Sharma, MD (she/her/hers) – Vanderbilt University Medical Center ### 2118874###Speaker###Physician (Hematology & Transfusion Medicine)###Vanderbilt University Medical Center###
Speaker: Deva Sharma, MD (she/her/hers) – Vanderbilt University Medical Center
### she/her/hers @@@ Jennifer Andrews, MD, MSc – Vanderbilt University Medical Center ### 837313###Speaker###Physician###Vanderbilt University Medical Center###
Speaker: Jennifer Andrews, MD, MSc – Vanderbilt University Medical Center
### @@@ Ann Abiola Ogbenna, MBBS, MSc (Public health, Medical statistic option), FMCPath (she/her/hers) – College of Medicine, University of Lagos/ Lagos University Teaching Hospital, Lagos Nigeria ### 2392512###Speaker###Senior Lecturer/Consultant Haematologist###College of Medicine, University of Lagos/ Lagos University Teaching Hospital, Lagos Nigeria###
Speaker: Ann Abiola Ogbenna, MBBS, MSc (Public health, Medical statistic option), FMCPath (she/her/hers) – College of Medicine, University of Lagos/ Lagos University Teaching Hospital, Lagos Nigeria
### she/her/hers AM24-MN-02-L
A Non-Testing Strategy For Protecting The Blood Supply From Mosquito-Borne Infections In Florida (OA1-AM24-ST-17)
Favorite

Rita A. Reik, MD FCAP (she/her/hers) – OneBlood ### 833010###Presenting Author###Chief Medical Officer###OneBlood###
Presenting Author: Rita A. Reik, MD FCAP (she/her/hers) – OneBlood
### she/her/hers OA1-AM24-ST-17
A Novel Small Molecule Drug-Based Approach for Treating Beta-Globinopathies (OA1-AM24-TU-06)
Favorite

Jun Liu, MD PhD (she/her/hers) – Mass General Brigham ### 1765718###Presenting Author###Medical director, Cellular Therapies Program###Mass General Brigham###
Presenting Author: Jun Liu, MD PhD (she/her/hers) – Mass General Brigham
### she/her/hers OA1-AM24-TU-06
A Quality Bootcamp for Facility Compliance and Conformance to AABB Standards and Federal Regulations (AM24-SN-16-L)
Favorite

Tracie Nichols, MS, MLS (ASCP), SBBcm, CABP, CQA (ASQ) (she/her/hers) – AABB ### 2042509###Speaker###Senior Director of Accreditation Compliance###AABB###
Speaker: Tracie Nichols, MS, MLS (ASCP), SBBcm, CABP, CQA (ASQ) (she/her/hers) – AABB
### she/her/hers @@@ Faiqa Sadique, MS, SBB, MT(ASCP), CQA(ASQ) (she/her/hers) – AABB ### 2042511###Speaker###Director, CT Programs and Global Outreach###AABB###
Speaker: Faiqa Sadique, MS, SBB, MT(ASCP), CQA(ASQ) (she/her/hers) – AABB
### she/her/hers @@@ Matthew Swingholm, MS, MLS(ASCP)SBBcm – AABB ### 2042510###Speaker###Project Development Manager###AABB###
Speaker: Matthew Swingholm, MS, MLS(ASCP)SBBcm – AABB
### @@@ Melanie Sloan, MS, MLS(ASCP)SBB, CQA(ASQ) (she/her/hers) – AABB ### 2042508###Speaker###Senior Director of Strategic Accreditation Operations ###AABB###
Speaker: Melanie Sloan, MS, MLS(ASCP)SBB, CQA(ASQ) (she/her/hers) – AABB
### she/her/hers AM24-SN-16-L
AABB RBC and Platelet International Guidelines: What is new: Liberally Restrictive and Restrictively Liberal? (AM24-ST-18-L)
Favorite

Claudia Cohn, MD, Phd – University of Minnesota ### 2362155###Program Chair###Professor of Laboratory Medicine and Pathology, Dir. Blood Bank Lab., Ass. Dir. Clinical Lab.###University of Minnesota###
Program Chair: Claudia Cohn, MD, Phd – University of Minnesota
### @@@ Simon J. Stanworth, DPhil, MD – University of Oxford ### 2362163###Speaker###Professor of Haematology and Transfusion Medicine###University of Oxford###
Speaker: Simon J. Stanworth, DPhil, MD – University of Oxford
### @@@ Ryan A. Metcalf, MD – ARUP Labs and Utah School of Medicine ### 1762752###Speaker###Section Chief, Transfusion Medicine###ARUP Labs and Utah School of Medicine###
Speaker: Ryan A. Metcalf, MD – ARUP Labs and Utah School of Medicine
### @@@ Monica B. Pagano, MD (she/her/hers) – University of Washington ### 832984###Speaker###Division Head of Transfusion Medicine###University of Washington###
Speaker: Monica B. Pagano, MD (she/her/hers) – University of Washington
### she/her/hers AM24-ST-18-L
Abnormal Pre-Donation Blood Pressure And Adverse Events In Whole Blood And Apheresis Donation (OA1-AM24-SN-15)
Favorite

Catherine Thibeault, RN, B.Sc. (she/her/hers) – Medical Affairs and Innovation ### 2418198###Presenting Author###Associate director###Medical Affairs and Innovation###
Presenting Author: Catherine Thibeault, RN, B.Sc. (she/her/hers) – Medical Affairs and Innovation
### she/her/hers OA1-AM24-SN-15
ABO*AW.09 is a common ABO subgroup involved in ABO discrepancies in US patients and blood donors (OA1-AM24-TU-15)
Favorite

Ella Massie-Schuh, MS (she/her/hers) – American Red Cross ### 2418225###Presenting Author###Scientist II###American Red Cross###
Presenting Author: Ella Massie-Schuh, MS (she/her/hers) – American Red Cross
### she/her/hers OA1-AM24-TU-15
Acute Kidney Injury to Evaluate Amustaline/Glutathione Pathogen Reduced Red Cells in Cardiac Surgery: Outcomes of the ReCePI Phase III Clinical Trial (PL1-SN-27)
Favorite

Edward L. Snyder, MD – Yale University ### 837071###Presenting Author###Professor Laboratory Medicine & Pathology###Yale University###
Presenting Author: Edward L. Snyder, MD – Yale University
### PL1-SN-27
ADAMTS13-Chimeric Auto-Antigen Receptor (CAAR) T cells To Target Autoreactive B cells As A Treatment For Immune-mediated Thrombotic Thrombocytopenic Purpura (PL2-SN-27)
Favorite

Roman H. Khadka, PhD – University of Pennsylvania ### 2418167###Presenting Author###Postdoctoral Fellow###University of Pennsylvania###
Presenting Author: Roman H. Khadka, PhD – University of Pennsylvania
### PL2-SN-27
Addressing Racial Disparities Across Donation Products for Marginalized Peoples (AM24-TU-03-L)
Favorite

Sylvia Okonofua, n/a – Black Donors Save Lives ### 2362107###Program Chair###Executive Director###Black Donors Save Lives###
Program Chair: Sylvia Okonofua, n/a – Black Donors Save Lives
### @@@ Sylvia Okonofua, n/a – Black Donors Save Lives ### 2362107###Speaker###Executive Director###Black Donors Save Lives###
Speaker: Sylvia Okonofua, n/a – Black Donors Save Lives
### @@@ Warren Fingrut, MD – University of Texas MD Anderson Cancer Center ### 2362108###Speaker###Assistant Professor###University of Texas MD Anderson Cancer Center###
Speaker: Warren Fingrut, MD – University of Texas MD Anderson Cancer Center
### AM24-TU-03-L
Aggregates in Cold Stored Platelet Units have Diverse Phenotypes that are Removed by Transfusion Filters (OA1-AM24-MN-14)
Favorite

Kathleen Kelly, PhD – Vitalant Innovation Center ### 2118039###Presenting Author######Vitalant Innovation Center###
Presenting Author: Kathleen Kelly, PhD – Vitalant Innovation Center
### OA1-AM24-MN-14
Alloimmunization to RBC Transfusion: Mechanisms, Interventions, and Future Directions (presented by James Zimring, Tibor Greenwalt Memorial Award recipient) (AM24-MN-11-L)
Favorite

Ronit Slotky, PhD, MSc, CABP (she/her/hers) – Hackensack University Medical Center ### 837472###Program Chair###Director, Cell therapies Manufacturing Facility###Hackensack University Medical Center###
Program Chair: Ronit Slotky, PhD, MSc, CABP (she/her/hers) – Hackensack University Medical Center
### she/her/hers @@@ Krystalyn E. Hudson, PhD (she/her/hers) – Columbia University Irving Medical Center ### 832675###Award Presenter###Associate Professor###Columbia University Irving Medical Center###
Award Presenter: Krystalyn E. Hudson, PhD (she/her/hers) – Columbia University Irving Medical Center
### she/her/hers @@@ James Zimring, MD, PhD – University of Virginia ### 833325###Award Recipient ###Professor###University of Virginia###
Award Recipient : James Zimring, MD, PhD – University of Virginia
### AM24-MN-11-L
An antibody in the Gerbich Blood System Against a Novel High Prevalence Antigen Named GEGA (OA1-AM24-ST-19)
Favorite

Randall W. Velliquette, n/a – New York Blood Center Enterprises ### 2118270###Presenting Author######New York Blood Center Enterprises###
Presenting Author: Randall W. Velliquette, n/a – New York Blood Center Enterprises
### OA1-AM24-ST-19
Antioxidant Responses Regulate RBC Alloimmunization (PL3-SN-27)
Favorite

David R. Gibb, MD PhD (he/him/his) – Cedars-Sinai Medical Center ### 2418181###Presenting Author###Assistant Professor###Cedars-Sinai Medical Center###
Presenting Author: David R. Gibb, MD PhD (he/him/his) – Cedars-Sinai Medical Center
### he/him/his PL3-SN-27
Ask the FDA and CMS/CLIA (AM24-MN-27-L)
Favorite

Karen E. Palmer, MT(ASCP) CQA(ASQ) – AABB ### 1762699###Program Chair###Director, Regulatory Affairs###AABB###
Program Chair: Karen E. Palmer, MT(ASCP) CQA(ASQ) – AABB
### @@@ Orieji Illoh, MD, CBER, OBRR ### 2487171###Speaker#########
Speaker: Orieji Illoh, MD, CBER, OBRR
### @@@ Catherine McGraw, MSN, RN – CBER, OBRR ### 1794627###Speaker###Consumer Safety Officer###CBER, OBRR###
Speaker: Catherine McGraw, MSN, RN – CBER, OBRR
### @@@ Racquel N. East, MS, MLS(ASCP)SBB, CBER, OBRR – CBER, OBRR ### 2487174###Speaker###Clinical Laboratory Scientist###CBER, OBRR###
Speaker: Racquel N. East, MS, MLS(ASCP)SBB, CBER, OBRR – CBER, OBRR
### @@@ Irma Sison, MD, MBA – Office of Therapeutic Products ### 2503860###Speaker###Director###Office of Therapeutic Products###
Speaker: Irma Sison, MD, MBA – Office of Therapeutic Products
### AM24-MN-27-L
Assessing Comparability of Canadian SARS-CoV-2 Serological Surveillance Studies While Adjusting for Representativeness (OA1-AM24-ST-26)
Favorite

W. Alton Russell, PhD (he/him/his) – McGill School of Population and Global Health ### 2119472###Presenting Author###Assistant Professor###McGill School of Population and Global Health###
Presenting Author: W. Alton Russell, PhD (he/him/his) – McGill School of Population and Global Health
### he/him/his OA1-AM24-ST-26
Assessment of Blood Safety Implications of Increasing Use of HIV Treatment and Prevention Therapies (OA1-AM24-ST-27)
Favorite

Brian Custer, PhD, MPH (he/him/his) – Vitalant Research Institute ### 2118110###Presenting Author###Director###Vitalant Research Institute###
Presenting Author: Brian Custer, PhD, MPH (he/him/his) – Vitalant Research Institute
### he/him/his OA1-AM24-ST-27
B
Beyond CAR T: Non-Conventional Applications of CAR Technology in Biotherapies (AM24-TU-01-L)
Favorite

Indira Guleria, PhD, D(ABHI), CABP(H) – BIDMC and Harvard Medical School ### 2362161###Program Chair###Assistant Professor of Medicine###BIDMC and Harvard Medical School###
Program Chair: Indira Guleria, PhD, D(ABHI), CABP(H) – BIDMC and Harvard Medical School
### @@@ Kate Rochlin, PhD (she/her/hers) – In8Bio ### 2438870###Speaker###COO###In8Bio###
Speaker: Kate Rochlin, PhD (she/her/hers) – In8Bio
### she/her/hers @@@ Rafet Basar, MD – MD Anderson ### 2480994###Speaker###Assistant Professor###MD Anderson###
Speaker: Rafet Basar, MD – MD Anderson
### AM24-TU-01-L
Beyond Gender-Based Sexual Activity Blood Safety Rules - Outcomes and Next Steps (AM24-SN-21-L)
Favorite

Isra Levy, MB,BCh, MSc, FRCPC (he/him/his) – Canadian Blood Services ### 2362109###Program Chair###Vice President, Medical Affairs and Innovation###Canadian Blood Services###
Program Chair: Isra Levy, MB,BCh, MSc, FRCPC (he/him/his) – Canadian Blood Services
### he/him/his @@@ Katy Davison, MSc (she/her/hers) – Blood Safety, UK Health Security Agency London, England, United Kingdom ### 837496###Speaker###Principal Scientist Epidemiology###Blood Safety, UK Health Security Agency London, England, United Kingdom###
Speaker: Katy Davison, MSc (she/her/hers) – Blood Safety, UK Health Security Agency London, England, United Kingdom
### she/her/hers @@@ Joanne Pink, MD, FRCPA, FRACP – Australian Red Cross Lifeblood ### 1765585###Speaker###Chief Medical Officer###Australian Red Cross Lifeblood###
Speaker: Joanne Pink, MD, FRCPA, FRACP – Australian Red Cross Lifeblood
### @@@ Mindy Goldman, MD, FRCPC (she/her/hers) – Canadian Blood Services ### 2118683###Speaker###Medical Director###Canadian Blood Services###
Speaker: Mindy Goldman, MD, FRCPC (she/her/hers) – Canadian Blood Services
### she/her/hers AM24-SN-21-L
Blood Bank Guy Essentials LIVE! (AM24-TU-04-L)

Favorite

D. Joe Chaffin, MD – Loma Linda University ### 833583###Program Chair###Transfusion Medicine Educator###Loma Linda University###
Program Chair: D. Joe Chaffin, MD – Loma Linda University
### @@@ Sue T. Johnson, MSTM, MLS(ASCP)SBBCM – Versiti ### 1762728###Speaker###Director, Clinical Education###Versiti###
Speaker: Sue T. Johnson, MSTM, MLS(ASCP)SBBCM – Versiti
### @@@ Meghan Delaney, DO, MPH – Childrens National Hospital ### 832724###Speaker###Chief, Pathology & Laboratory Medicine###Childrens National Hospital###
Speaker: Meghan Delaney, DO, MPH – Childrens National Hospital
### @@@ Kevin J. Land, MD – Vitalant ### 837509###Speaker###VP Clinical Services###Vitalant###
Speaker: Kevin J. Land, MD – Vitalant
### AM24-TU-04-L
Blood donation, Race and Transfusion Medicine: Looking Back to Move Forward (AM24-SN-14-L)
Favorite

Patricia Brunker, MD, DPhil (she/her/hers) – Massachusetts General Hospital ### 2419538###Program Chair###Medical Director, Blood Transfusion Service Patient Services###Massachusetts General Hospital###
Program Chair: Patricia Brunker, MD, DPhil (she/her/hers) – Massachusetts General Hospital
### she/her/hers @@@ Richard L. Haspel, MD, PhD (he/him/his) – Beth Israel Deaconess Medical Center and Harvard Medical School ### 837473###Speaker###Professor of Pathology###Beth Israel Deaconess Medical Center and Harvard Medical School###
Speaker: Richard L. Haspel, MD, PhD (he/him/his) – Beth Israel Deaconess Medical Center and Harvard Medical School
### he/him/his @@@ Yvette M. Miller, MD, ABIHM (she/her/hers) – American Red Cross ### 832697###Speaker###Executive Medical Officer###American Red Cross###
Speaker: Yvette M. Miller, MD, ABIHM (she/her/hers) – American Red Cross
### she/her/hers AM24-SN-14-L
Blood Donor Center Staffing Analysis – Armed Services Blood Program (AM24-SN-07-L)
Favorite

Leslie Riggs, MS, MT (ASCP), SBB – Armed Services Blood Program ### 1762719###Program Chair######Armed Services Blood Program###
Program Chair: Leslie Riggs, MS, MT (ASCP), SBB – Armed Services Blood Program
### @@@ Mary Ann Spott, PhD, MPA, MSIS, MBA (she/her/hers) – Defense Health Agency, J-3/5/7, Armed Services Blood Program Division (ASBPD) ### 2364559###Speaker###Deputy Division Chief, ASBPD###Defense Health Agency, J-3/5/7, Armed Services Blood Program Division (ASBPD)###
Speaker: Mary Ann Spott, PhD, MPA, MSIS, MBA (she/her/hers) – Defense Health Agency, J-3/5/7, Armed Services Blood Program Division (ASBPD)
### she/her/hers AM24-SN-07-L
Blood donor SARS-CoV-2 Infection and Vaccination is not Associated with Adverse Outcomes in Plasma and Platelet Transfusion Recipients Without Acute COVID-19 (OA2-AM24-ST-26)
Favorite

Nareg Roubinian, MD, MPHTM – Kaiser Permanente Northern California Division of Research ### 2119443###Presenting Author###Clinical Investigator###Kaiser Permanente Northern California Division of Research###
Presenting Author: Nareg Roubinian, MD, MPHTM – Kaiser Permanente Northern California Division of Research
### OA2-AM24-ST-26
C
Certified Advanced Biotherapies Professional (CABP) Exam Prep (AM24-ST-28-L)
Favorite

Bill Ward, MT(ASCP), DLM, LSSGB, CABP – Vitalant ### 2419484###Speaker######Vitalant###
Speaker: Bill Ward, MT(ASCP), DLM, LSSGB, CABP – Vitalant
### @@@ Jennifer Chain, Dr – CSM Consulting, LLC ### 2362131###Speaker###Cellular Starting Material Consultant###CSM Consulting, LLC###
Speaker: Jennifer Chain, Dr – CSM Consulting, LLC
### AM24-ST-28-L
Case Studies: Cyber Threats in Healthcare (AM24-ST-29-L)

Favorite

Mandy F. O'Leary, MD, MPH – H. Lee Moffitt Cancer Center ### 1762729###Program Chair###Pathologist###H. Lee Moffitt Cancer Center###
Program Chair: Mandy F. O'Leary, MD, MPH – H. Lee Moffitt Cancer Center
### @@@ Martin Grable – OneBlood ### 2483311###Speaker###Exec. Vice President, Chief Financial an Administrative Officer###OneBlood###
Speaker: Martin Grable – OneBlood
### @@@ Sarah Harm, MD, MSc (she/her/hers) – University of Vermont Medical Center ### 2043454###Speaker###Pathologist; Associate Professor; Network Vice Chair Lab Medicine###University of Vermont Medical Center###
Speaker: Sarah Harm, MD, MSc (she/her/hers) – University of Vermont Medical Center
### she/her/hers @@@ Zach Nelson, CISSP GSOM GCTI – Health-ISAC, Inc. ### 2483312###Speaker###Vice President, Threat Operations Center###Health-ISAC, Inc.###
Speaker: Zach Nelson, CISSP GSOM GCTI – Health-ISAC, Inc.
### @@@ Susan Robinson, MBBS, MDRes, FRCP, FRCPath (she/her/hers) – Guy’s and St Thomas’ NHS Foundation Trust ### 2483313###Speaker###GSTT Clinical Lead Pathology, Clinical Director for Haematology, Haemostasis, Cellular Pathology, Oncology & Haematology Clinical Trials; Haematologist ###Guy’s and St Thomas’ NHS Foundation Trust###
Speaker: Susan Robinson, MBBS, MDRes, FRCP, FRCPath (she/her/hers) – Guy’s and St Thomas’ NHS Foundation Trust
### she/her/hers AM24-ST-29-L
CD47 Expression on Transfused RBCs Impacts Antibody-Mediated Clearance and Antigen Loss in a Mouse Model (OA1-AM24-TU-14)
Favorite

Ryan P. Jajosky, MD – Brigham and Women's Hospital ### 1762776###Presenting Author######Brigham and Women's Hospital###
Presenting Author: Ryan P. Jajosky, MD – Brigham and Women's Hospital
### OA1-AM24-TU-14
Cell Therapy: Creative Inventory Management & Discard (AM24-MN-31-L)
Favorite

Brenda Alder, MS, MLS(ASCP)SBB, CABPH(AABB) (she/her/hers) – Northside Hospital Atlanta ### 2362182###Program Chair###Quality Assurance and Regulatory Manager Cell Therapy Lab and tissue banks###Northside Hospital Atlanta###
Program Chair: Brenda Alder, MS, MLS(ASCP)SBB, CABPH(AABB) (she/her/hers) – Northside Hospital Atlanta
### she/her/hers @@@ Jennifer Westerman, MT(ASCP) (she/her/hers) – Northside Hospital Atlanta ### 2362183###Speaker###Stem Cell Lab Coordinator###Northside Hospital Atlanta###
Speaker: Jennifer Westerman, MT(ASCP) (she/her/hers) – Northside Hospital Atlanta
### she/her/hers @@@ Rupal Brahmbhatt, MLS (AMT), CABP (AABB) – Northside Hospital Atlanta ### 2362184###Speaker###Cell Therapy Progenitor Senior Specialist###Northside Hospital Atlanta###
Speaker: Rupal Brahmbhatt, MLS (AMT), CABP (AABB) – Northside Hospital Atlanta
### AM24-MN-31-L
Characterization of the Stored Platelet Unit Lipidome and its Relationship to Donor Sex and Hemostatic Function (OA2-AM24-MN-14)
Favorite

Jack Killinger, n/a – University of Pittsburgh ### 2418372###Presenting Author######University of Pittsburgh###
Presenting Author: Jack Killinger, n/a – University of Pittsburgh
### OA2-AM24-MN-14
Choose Your Own Adventure: Exploring the Depths of Serology and Peaks of Genomics (AM24-MN-28-L)
Favorite

Lynsi Rahorst, MHPE, MLS(ASCP)SBB – New York Blood Center Enterprises ### 837514###Program Chair###Manager, Education & Training, IRL/Genomics Labs###New York Blood Center Enterprises###
Program Chair: Lynsi Rahorst, MHPE, MLS(ASCP)SBB – New York Blood Center Enterprises
### @@@ Lynsi Rahorst, MHPE, MLS(ASCP)SBB – New York Blood Center Enterprises ### 837514###Speaker###Manager, Education & Training, IRL/Genomics Labs###New York Blood Center Enterprises###
Speaker: Lynsi Rahorst, MHPE, MLS(ASCP)SBB – New York Blood Center Enterprises
### @@@ Sunitha Vege, MS – New York Blood Center ### 832987###Speaker###Sr Technical Director, Genomics###New York Blood Center###
Speaker: Sunitha Vege, MS – New York Blood Center
### @@@ Michelle Lodermeier, MBA, MLS(ASCP)SBB (she/her/hers) – American Red Cross ### 1762671###Speaker###Sr. Program Manager, BBT###American Red Cross###
Speaker: Michelle Lodermeier, MBA, MLS(ASCP)SBB (she/her/hers) – American Red Cross
### she/her/hers AM24-MN-28-L
Clinical Evaluation of Leukoreduced Red Blood Cells After Automated Separation of Whole Blood by the Reveos™ System and Storage for 42 Days (OA1-AM24-SN-23)
Favorite

Rebecca Sedjo, PhD, MSPH (she/her/hers) – Terumo BCT, Inc ### 2418160###Presenting Author###Manager, Clinical Development###Terumo BCT, Inc###
Presenting Author: Rebecca Sedjo, PhD, MSPH (she/her/hers) – Terumo BCT, Inc
### she/her/hers OA1-AM24-SN-23
Clinical Outcomes for Patients Transfused Above and Below Guideline Recommended Hemoglobin Thresholds (OA1-AM24-MN-08)
Favorite

Sheharyar Raza, MD, FRCPC (he/him/his) – Canadian Blood Services ### 2418337###Presenting Author######Canadian Blood Services###
Presenting Author: Sheharyar Raza, MD, FRCPC (he/him/his) – Canadian Blood Services
### he/him/his OA1-AM24-MN-08
Clinical Relevance of ABO Antibodies and the New Era of Lectin Array Analysis of RBC ABO Glycosylation (AM24-MN-03-L)
Favorite

Gregory A. Denomme, PhD (he/him/his) – Grifols Laboratory Solutions ### 2118137###Speaker###Laboratory Director and Head of R&D###Grifols Laboratory Solutions###
Speaker: Gregory A. Denomme, PhD (he/him/his) – Grifols Laboratory Solutions
### he/him/his @@@ Sean R. Stowell, MD PhD – Brigham and Women's Hospital ### 1762701###Speaker###Vice Chair for Transfusion Medicine###Brigham and Women's Hospital###
Speaker: Sean R. Stowell, MD PhD – Brigham and Women's Hospital
### @@@ Jian Chen, MD, PhD – Houston Methodist Hospital ### 2118357###Program Chair###Co-director, Transfusion services###Houston Methodist Hospital###
Program Chair: Jian Chen, MD, PhD – Houston Methodist Hospital
### AM24-MN-03-L
Clinically Significant Alloantibody to High-Incidence CD36 in a Patient with Sickle Cell Disease and Hyperhemolysis, A Novel Finding (OA2-AM24-ST-19)
Favorite

Jensyn Cone Sullivan, MD – Department of Pathology, Michigan Medicine at the University of Michigan ### 2362177###Presenting Author###Director, Blood Bank###Department of Pathology, Michigan Medicine at the University of Michigan###
Presenting Author: Jensyn Cone Sullivan, MD – Department of Pathology, Michigan Medicine at the University of Michigan
### OA2-AM24-ST-19
Coming to Terms with Changing Transfusion Practices in the NICU (AM24-TU-16-L)
Favorite

Rida Hasan, MD – University Of Washington Medical Center ### 1765753###Program Chair###Assistant Professor###University Of Washington Medical Center###
Program Chair: Rida Hasan, MD – University Of Washington Medical Center
### @@@ Nabiha Saifee, MD PhD – Seattle Children's Hospital ### 1762662###Speaker###Assistant Professor, Transfusion Service Medical Director###Seattle Children's Hospital###
Speaker: Nabiha Saifee, MD PhD – Seattle Children's Hospital
### @@@ Ravi M. Patel, MD, MSc (he/him/his) – Emory University and Children's Healthcare of Atlanta ### 836984###Speaker###Professor of Pediatrics###Emory University and Children's Healthcare of Atlanta###
Speaker: Ravi M. Patel, MD, MSc (he/him/his) – Emory University and Children's Healthcare of Atlanta
### he/him/his AM24-TU-16-L
Comparative Analysis of Room Temperature (RT) Day 7 and Cold Storage (CS) Day 21 Platelets: An Interim Evaluation of the Chilled Platelet Study in vitro (CHIPSiv) (OA3-AM24-MN-14)
Favorite

Irona Khandaker, MBBS, PhD – University of Pittsburgh ### 2418347###Presenting Author######University of Pittsburgh###
Presenting Author: Irona Khandaker, MBBS, PhD – University of Pittsburgh
### OA3-AM24-MN-14
Comparison of SARS-CoV-2 IgG Antibodies between Convalescent Plasma and Conventional Plasma Units (OA3-AM24-ST-26)
Favorite

Andrew Sulaiman, DO, PhD (he/him/his) – Johns Hopkins University ### 2418288###Presenting Author###PGY2 Clinical Pathology Resident###Johns Hopkins University###
Presenting Author: Andrew Sulaiman, DO, PhD (he/him/his) – Johns Hopkins University
### he/him/his OA3-AM24-ST-26
Complication Rates in Patients with Sickle Cell Disease on Hydroxyurea Managed With or Without Pre-Anesthesia Transfusion (OA2-AM24-MN-39)
Favorite

Naomi Gunawardena, MD (she/her/hers) – Children's Hospital of Philadelphia ### 2418329###Presenting Author######Children's Hospital of Philadelphia###
Presenting Author: Naomi Gunawardena, MD (she/her/hers) – Children's Hospital of Philadelphia
### she/her/hers OA2-AM24-MN-39
Coverage and Reimbursement Policy 101 for Transfusion Medicine and Cellular Therapies (AM24-ST-11-L)
Favorite

Susan N. Leppke, MPH (she/her/hers) – AABB ### 1762770###Program Chair###Senior Director, Public Policy & Strategic Partnerships###AABB###
Program Chair: Susan N. Leppke, MPH (she/her/hers) – AABB
### she/her/hers @@@ Justin Halls, MD, MPH (he/him/his) – Phoenix Children's Hospital ### 2362140###Speaker###Transfusion Faculty###Phoenix Children's Hospital###
Speaker: Justin Halls, MD, MPH (he/him/his) – Phoenix Children's Hospital
### he/him/his @@@ Richard R. Gammon, MD – Carter BloodCare ### 832453###Speaker###Chief Medical Officer###Carter BloodCare###
Speaker: Richard R. Gammon, MD – Carter BloodCare
### AM24-ST-11-L
Crisis in the Rural Hospital Without Access to Blood Transfusion: Innovative Strategies to Address Global Blood Deserts and the Blood D.E.S.E.R.T. Coalition (AM24-SN-24-L)
Favorite

LINDA S. Barnes, DrPH, MHA, RAC, CABP(H) (she/her/hers) – University of Pittsburgh ### 2038705###Program Chair###Visiting Assistant Research Professor###University of Pittsburgh###
Program Chair: LINDA S. Barnes, DrPH, MHA, RAC, CABP(H) (she/her/hers) – University of Pittsburgh
### she/her/hers @@@ Nakul P. Raykar, MD MPH FACS (he/him/his) – Harvard Medical School ### 2038703###Speaker###Assistant Professor of Surgery###Harvard Medical School###
Speaker: Nakul P. Raykar, MD MPH FACS (he/him/his) – Harvard Medical School
### he/him/his @@@ Asma Aliawadh, MBBS, MHM, MIPH (she/her/hers) – Langata and Kibera Sub-Counties, Kenya ### 2362153###Speaker###Medical Officer###Langata and Kibera Sub-Counties, Kenya###
Speaker: Asma Aliawadh, MBBS, MHM, MIPH (she/her/hers) – Langata and Kibera Sub-Counties, Kenya
### she/her/hers @@@ Andrew Cap, MS, MD, PhD (he/him/his) – U.S. Army Institute of Surgical Research ### 2118937###Speaker######U.S. Army Institute of Surgical Research###
Speaker: Andrew Cap, MS, MD, PhD (he/him/his) – U.S. Army Institute of Surgical Research
### he/him/his @@@ Caroline Wesonga Wangamati, MSc MA (she/her/hers) – Coalition of Blood for Africa ### 2480617###Speaker###Team Lead - COBA###Coalition of Blood for Africa###
Speaker: Caroline Wesonga Wangamati, MSc MA (she/her/hers) – Coalition of Blood for Africa
### she/her/hers @@@ Lucy Asamoah-Akuoko, MD MPH PHD – National Blood Service Ghana ### 2118240###Speaker###Head, Research, Planning, Monitoring and Evaluation###National Blood Service Ghana###
Speaker: Lucy Asamoah-Akuoko, MD MPH PHD – National Blood Service Ghana
### AM24-SN-24-L
Critical Role of an Assay Lifecycle in Analytical Development for Cell and Gene Therapy Products (AM24-ST-21-L)
Favorite

Scott Jones, PhD (he/him/his) – BioBridge Global ### 833427###Program Chair###Senior Vice president, Chiek Scientific Officer###BioBridge Global###
Program Chair: Scott Jones, PhD (he/him/his) – BioBridge Global
### he/him/his @@@ Scott Jones, PhD (he/him/his) – BioBridge Global ### 833427###Speaker###Senior Vice president, Chiek Scientific Officer###BioBridge Global###
Speaker: Scott Jones, PhD (he/him/his) – BioBridge Global
### he/him/his @@@ Brent Morse, MS – Dark Horse Consulting Group ### 2362158###Speaker###Principal###Dark Horse Consulting Group###
Speaker: Brent Morse, MS – Dark Horse Consulting Group
### @@@ Emmanuel Casasola (he/him/his) – BioBridge Global ### 2119042###Speaker###Executive Director, Global Quality###BioBridge Global###
Speaker: Emmanuel Casasola (he/him/his) – BioBridge Global
### he/him/his AM24-ST-21-L
Cross-Cultural Conversations: Advancing Equity Through Interprofessional Education: A Template For Organizational Change (presented by Yvette Miller, Hemphill-Jordan Leadership Award recipient) (AM24-ST-24-L)
Favorite

Patrick W. Ooley, MS, MLS(ASCP) CMQ/OE (ASQ) CQA (he/him/his) – Vitalant ### 2119559###Program Chair###Vice President Blood Services Division Quality Services###Vitalant###
Program Chair: Patrick W. Ooley, MS, MLS(ASCP) CMQ/OE (ASQ) CQA (he/him/his) – Vitalant
### he/him/his @@@ Arthur W. Bracey, MD ### 2482922###Award Presenter#########
Award Presenter: Arthur W. Bracey, MD
### @@@ Yvette M. Miller, MD, ABIHM (she/her/hers) – American Red Cross ### 832697###Award Recipient ###Executive Medical Officer###American Red Cross###
Award Recipient : Yvette M. Miller, MD, ABIHM (she/her/hers) – American Red Cross
### she/her/hers AM24-ST-24-L
Cross-cultural Conversations: Our Words and Interactions Have Power (AM24-TU-02-L)
Favorite

Yvette M. Miller, MD, ABIHM (she/her/hers) – American Red Cross ### 832697###Program Chair###Executive Medical Officer###American Red Cross###
Program Chair: Yvette M. Miller, MD, ABIHM (she/her/hers) – American Red Cross
### she/her/hers @@@ Yvette M. Miller, MD, ABIHM (she/her/hers) – American Red Cross ### 832697###Speaker###Executive Medical Officer###American Red Cross###
Speaker: Yvette M. Miller, MD, ABIHM (she/her/hers) – American Red Cross
### she/her/hers @@@ Tamara A. Henry, Ed.D (she/her/hers) – The George Washington University, Milken Institute School of Public Health ### 1792201###Speaker###Teaching Associate Professor###The George Washington University, Milken Institute School of Public Health###
Speaker: Tamara A. Henry, Ed.D (she/her/hers) – The George Washington University, Milken Institute School of Public Health
### she/her/hers AM24-TU-02-L
Cryopreserved Platelets: From Bench to Bedside (AM24-ST-22-L)
Favorite

DENESE C. MARKS, PhD – Australian Red Cross Lifeblood ### 833084###Program Chair###Research Program Leader- Product Development###Australian Red Cross Lifeblood###
Program Chair: DENESE C. MARKS, PhD – Australian Red Cross Lifeblood
### @@@ DENESE C. MARKS, PhD – Australian Red Cross Lifeblood ### 833084###Speaker###Research Program Leader- Product Development###Australian Red Cross Lifeblood###
Speaker: DENESE C. MARKS, PhD – Australian Red Cross Lifeblood
### @@@ Michael Reade, MBBS MPH DPhil DMedSc (he/him/his) – University of Queensland ### 2362137###Speaker###Director, Greater Brisbane Clinical School###University of Queensland###
Speaker: Michael Reade, MBBS MPH DPhil DMedSc (he/him/his) – University of Queensland
### he/him/his AM24-ST-22-L
D
DAT is Unnecessary for Newborns of RhIG-Positive Mothers (OA1-AM24-MN-07)
Favorite

Tsung-Lin Tsai, MD, PhD (he/him/his) – Bloodworks Northwest ### 2418318###Presenting Author###Medical and Laboratory Director###Bloodworks Northwest###
Presenting Author: Tsung-Lin Tsai, MD, PhD (he/him/his) – Bloodworks Northwest
### he/him/his OA1-AM24-MN-07
Debate: Liberal Versus Restrictive Transfusion Strategy in Acute Myocardial Infarction (AABB/ISBT Joint Session) (AM24-ST-10-L)

Favorite

Simon J. Stanworth, DPhil, MD – University of Oxford ### 2362163###Program Chair###Professor of Haematology and Transfusion Medicine###University of Oxford###
Program Chair: Simon J. Stanworth, DPhil, MD – University of Oxford
### @@@ Jeffrey L. Carson, MD (he/him/his) – Rutgers Robert Wood Johnson Medical School ### 2362164###Speaker###Provost and Distinguished Professor of Medicine###Rutgers Robert Wood Johnson Medical School###
Speaker: Jeffrey L. Carson, MD (he/him/his) – Rutgers Robert Wood Johnson Medical School
### he/him/his @@@ Aryeh Shander, MD, FCCM, FCCP, FASA – Englewood Health ### 2404511###Speaker######Englewood Health###
Speaker: Aryeh Shander, MD, FCCM, FCCP, FASA – Englewood Health
### AM24-ST-10-L
Deferrals for Pre-Exposure Prophylaxis (PrEP) for HIV Before and After the Switch to Sexual Risk Behaviour Screening (OA2-AM24-ST-27)
Favorite

Mindy Goldman, MD, FRCPC (she/her/hers) – Canadian Blood Services ### 2118683###Presenting Author###Medical Director###Canadian Blood Services###
Presenting Author: Mindy Goldman, MD, FRCPC (she/her/hers) – Canadian Blood Services
### she/her/hers OA2-AM24-ST-27
Designing a New Satellite Blood Distribution Location Within the Main Operating Room (OA1-AM24-MN-15)
Favorite

Nancy A. Drozewski, MLS(ASCP), SBB(ASCP)cm (she/her/hers) – Mayo Clinic Hospital, Arizona ### 2418237###Presenting Author###Technical Specialist II###Mayo Clinic Hospital, Arizona###
Presenting Author: Nancy A. Drozewski, MLS(ASCP), SBB(ASCP)cm (she/her/hers) – Mayo Clinic Hospital, Arizona
### she/her/hers OA1-AM24-MN-15
Developing An Engineered T Cell Therapy To Eliminate Inhibitors In Hemophilia A (OA2-AM24-TU-06)
Favorite

Morgan Hresko, BS, MS – Department of Pathology & Laboratory Medicine, University of Pennsylvania Perelman School of Medicine ### 2418169###Presenting Author######Department of Pathology & Laboratory Medicine, University of Pennsylvania Perelman School of Medicine###
Presenting Author: Morgan Hresko, BS, MS – Department of Pathology & Laboratory Medicine, University of Pennsylvania Perelman School of Medicine
### OA2-AM24-TU-06
Diagnostic Blood Loss: An Ignored Component of the Multidisciplinary Pillar of Patient Blood management (AM24-SN-13-L)
Favorite

Saptarshi Mandal, MD, MS, DABPath (CP, BBTM) (he/him/his) – AIIMS Jodhpur ### 837603###Program Chair###Additional Professor###AIIMS Jodhpur###
Program Chair: Saptarshi Mandal, MD, MS, DABPath (CP, BBTM) (he/him/his) – AIIMS Jodhpur
### he/him/his @@@ Saptarshi Mandal, MD, MS, DABPath (CP, BBTM) (he/him/his) – AIIMS Jodhpur ### 837603###Speaker###Additional Professor###AIIMS Jodhpur###
Speaker: Saptarshi Mandal, MD, MS, DABPath (CP, BBTM) (he/him/his) – AIIMS Jodhpur
### he/him/his AM24-SN-13-L
Diversity of Causes of C Discrepancies Identified by Automated Testing (OA3-AM24-ST-19)
Favorite

Alexis Smith, MS, MB(ASCP) – American Red Cross ### 2118025###Presenting Author######American Red Cross###
Presenting Author: Alexis Smith, MS, MB(ASCP) – American Red Cross
### OA3-AM24-ST-19
Donor and Recipient Safety and Transfusion Efficacy Research: Past, Present and Future (Presented by Michael Busch, Landsteiner-Alter Award Recipient) (AM24-MN-05-L)

Favorite

Aaron A.R. Tobian, MD, PhD – Johns Hopkins University ### 832713###Program Chair###Professor and Director of Transfusion Medicine###Johns Hopkins University###
Program Chair: Aaron A.R. Tobian, MD, PhD – Johns Hopkins University
### @@@ Brian Custer, PhD, MPH (he/him/his) – Vitalant Research Institute ### 2118110###Award Presenter###Director###Vitalant Research Institute###
Award Presenter: Brian Custer, PhD, MPH (he/him/his) – Vitalant Research Institute
### he/him/his @@@ Mike Busch, MD, PhD (he/him/his) – Vitalant Research Institute ### 2042503###Award Recipient ###Director Emeritus###Vitalant Research Institute###
Award Recipient : Mike Busch, MD, PhD (he/him/his) – Vitalant Research Institute
### he/him/his AM24-MN-05-L
Donor Specific Factors Associated with Aggregates in Cold Stored Platelets in 100% Plasma: (OA1-AM24-ST-13)
Favorite

Marjorie D. Bravo, MD, MPH (she/her/hers) – Vitalant ### 833343###Presenting Author###Medical Affairs Performance Improvement and Analytics Manager ###Vitalant###
Presenting Author: Marjorie D. Bravo, MD, MPH (she/her/hers) – Vitalant
### she/her/hers OA1-AM24-ST-13
Duffy (ACKR1): Antibodies, Chemokines and Potential Therapeutic Targets-Not Just for Transfusion Anymore (AM24-TU-09-L)
Favorite

Sally Campbell-Lee, MD – University of Illinois at Chicago ### 1765675###Program Chair###Director, Transfusion Medicine###University of Illinois at Chicago###
Program Chair: Sally Campbell-Lee, MD – University of Illinois at Chicago
### @@@ L.A. Naiche, PhD (she/her/hers) – University of Illinois at Chicago ### 2410525###Speaker###Research Assistant Professor###University of Illinois at Chicago###
Speaker: L.A. Naiche, PhD (she/her/hers) – University of Illinois at Chicago
### she/her/hers @@@ Rachel Martini, PhD – Davis Lab ### 2438402###Speaker###Postdoctoral Fellow###Davis Lab###
Speaker: Rachel Martini, PhD – Davis Lab
### AM24-TU-09-L
E
Enhance and Challenge Your Assessor Skills (AM24-ST-08-L)
Favorite

Jennifer White, MAT – AABB ### 2164179###Speaker###Accreditation Specialist###AABB###
Speaker: Jennifer White, MAT – AABB
### @@@ Tracie Nichols, MS, MLS (ASCP), SBBcm, CABP, CQA (ASQ) (she/her/hers) – AABB ### 2042509###Speaker###Senior Director of Accreditation Compliance###AABB###
Speaker: Tracie Nichols, MS, MLS (ASCP), SBBcm, CABP, CQA (ASQ) (she/her/hers) – AABB
### she/her/hers @@@ Faiqa Sadique, MS, SBB, MT(ASCP), CQA(ASQ) (she/her/hers) – AABB ### 2042511###Speaker###Director, CT Programs and Global Outreach###AABB###
Speaker: Faiqa Sadique, MS, SBB, MT(ASCP), CQA(ASQ) (she/her/hers) – AABB
### she/her/hers @@@ Matthew Swingholm, MS, MLS(ASCP)SBBcm – AABB ### 2042510###Speaker###Project Development Manager###AABB###
Speaker: Matthew Swingholm, MS, MLS(ASCP)SBBcm – AABB
### @@@ Melanie Sloan, MS, MLS(ASCP)SBB, CQA(ASQ) (she/her/hers) – AABB ### 2042508###Speaker###Senior Director of Strategic Accreditation Operations ###AABB###
Speaker: Melanie Sloan, MS, MLS(ASCP)SBB, CQA(ASQ) (she/her/hers) – AABB
### she/her/hers @@@ Sheila A. Jones – AABB ### 2164181###Speaker###Assessor Specialist###AABB###
Speaker: Sheila A. Jones – AABB
### AM24-ST-08-L
Enhancing Laboratory Competency with AI: Meeting AABB Standards for Cell Processing Facilities and Blood Banks (AM24-ST-20-L)

Favorite

WANXING CUI, PhD – MedStar Georgetown University Hospital ### 837259###Program Chair###Director, Cell Therapy Manufacturing Facility###MedStar Georgetown University Hospital###
Program Chair: WANXING CUI, PhD – MedStar Georgetown University Hospital
### @@@ Daisy Annette, MLS (ASCP) SBB – Our Blood Institute ### 2362165###Speaker###Quality Director###Our Blood Institute###
Speaker: Daisy Annette, MLS (ASCP) SBB – Our Blood Institute
### @@@ Jyotiska Biswas – ThinkTrends ### 2362187###Speaker###CEO###ThinkTrends###
Speaker: Jyotiska Biswas – ThinkTrends
### AM24-ST-20-L
Ensuring Blood Availability for Mass Casualty Events (AM24-SN-05-L)
Favorite

Nelson Hellwig, MBA – ACTS / Blood Emergency Readiness Corps ### 2362139###Program Chair###CEO / Administrator###ACTS / Blood Emergency Readiness Corps###
Program Chair: Nelson Hellwig, MBA – ACTS / Blood Emergency Readiness Corps
### @@@ Belinda A. Flores, MA – South Texas Blood and Tissue ### 2118691###Speaker###Senior Director of Product Management & Customer Relations###South Texas Blood and Tissue###
Speaker: Belinda A. Flores, MA – South Texas Blood and Tissue
### @@@ Amanda Hess, MBA (she/her/hers) – ImpactLife ### 1765589###Speaker###VP Donor Relations and Marketing###ImpactLife###
Speaker: Amanda Hess, MBA (she/her/hers) – ImpactLife
### she/her/hers AM24-SN-05-L
Evaluating the Influence of IMC-002, a Novel Anti-CD47 Monoclonal Antibody, on Pretransfusion Compatibility Testing (OA4-AM24-ST-19)
Favorite

Hyungsuk Kim, MD, PhD (he/him/his) – Department of Laboratory Medicine, Seoul National University Hospital ### 2418155###Presenting Author###Associate Professor###Department of Laboratory Medicine, Seoul National University Hospital###
Presenting Author: Hyungsuk Kim, MD, PhD (he/him/his) – Department of Laboratory Medicine, Seoul National University Hospital
### he/him/his OA4-AM24-ST-19
Evaluation of Coagulopathy in Pediatric Cohort Undergoing Massive Transfusion (OA2-AM24-MN-07)
Favorite

Nathan R. Wilken, MD (he/him/his) – Department of Pathology, Baylor College of Medicine Transfusion Medicine, Texas Children's Hospital ### 2418331###Presenting Author###Assistant Professor###Department of Pathology, Baylor College of Medicine Transfusion Medicine, Texas Children's Hospital###
Presenting Author: Nathan R. Wilken, MD (he/him/his) – Department of Pathology, Baylor College of Medicine Transfusion Medicine, Texas Children's Hospital
### he/him/his OA2-AM24-MN-07
Evolving Blood Donor Demographics in the United States During the COVID-19 Pandemic (OA4-AM24-ST-26)
Favorite

W. Alton Russell, PhD (he/him/his) – McGill School of Population and Global Health ### 2119472###Presenting Author###Assistant Professor###McGill School of Population and Global Health###
Presenting Author: W. Alton Russell, PhD (he/him/his) – McGill School of Population and Global Health
### he/him/his OA4-AM24-ST-26
Expired Blood Transfusion and Mortality Outcomes in Combat Trauma Patients (OA2-AM24-SN-23)
Favorite

Brian Riley, MA, Major – University of Washington School of Medicine, US Air Force Reserve ### 2418087###Presenting Author###Medical Student, MS3###University of Washington School of Medicine, US Air Force Reserve###
Presenting Author: Brian Riley, MA, Major – University of Washington School of Medicine, US Air Force Reserve
### OA2-AM24-SN-23
External Validation of Machine Learning Models Predicting Iron Recovery After Blood Donation (OA2-AM24-ST-17)
Favorite

W. Alton Russell, PhD (he/him/his) – McGill School of Population and Global Health ### 2119472###Presenting Author###Assistant Professor###McGill School of Population and Global Health###
Presenting Author: W. Alton Russell, PhD (he/him/his) – McGill School of Population and Global Health
### he/him/his OA2-AM24-ST-17
F
Ferritin Testing of Adult Donors with a Prior Low Hemoglobin (Hb) Deferral (OA3-AM24-ST-17)
Favorite

Ralph R. Vassallo, MD FACP – Vitalant ### 2419098###Presenting Author###EVP / Chief Medical & Scientific Officer###Vitalant###
Presenting Author: Ralph R. Vassallo, MD FACP – Vitalant
### OA3-AM24-ST-17
Four Novel ABO Enhancer Variants in Patients With Altered Phenotypes (OA2-AM24-TU-15)
Favorite

June J. Fuertes, MLS(ASCP) (he/him/his) – New York Blood Center Enterprises ### 1765671###Presenting Author######New York Blood Center Enterprises###
Presenting Author: June J. Fuertes, MLS(ASCP) (he/him/his) – New York Blood Center Enterprises
### he/him/his OA2-AM24-TU-15
Freeze-Dried Platelets Decrease Bleeding in Refractory Thrombocytopenic Patients with Hematological Malignancies (PL4-SN-27)
Favorite

Maro Ohanian, DO – MD Anderson Cancer Center ### 2418272###Presenting Author######MD Anderson Cancer Center###
Presenting Author: Maro Ohanian, DO – MD Anderson Cancer Center
### PL4-SN-27
Frequency of Vasovagal Reactions with Large Volume Plasma Donations in Canada (OA2-AM24-SN-15)
Favorite

Aditi Khandelwal, MD MSc (she/her/hers) – Canadian Blood Services ### 2118680###Presenting Author###Medical Officer###Canadian Blood Services###
Presenting Author: Aditi Khandelwal, MD MSc (she/her/hers) – Canadian Blood Services
### she/her/hers OA2-AM24-SN-15
From Courts to Congress: Navigating the Healthcare Policy Landscape in 2024 (AM24-MN-36-L)
Favorite

Zbigniew M. Szczepiorkowski, MD, PhD – Dartmouth Health ### 2038685###Program Chair###Professor of Pathology and Laboratory Medicine/Director of Cellular Therapy Center###Dartmouth Health###
Program Chair: Zbigniew M. Szczepiorkowski, MD, PhD – Dartmouth Health
### @@@ Meghan Delaney, DO, MPH – Childrens National Hospital ### 832724###Speaker###Chief, Pathology & Laboratory Medicine###Childrens National Hospital###
Speaker: Meghan Delaney, DO, MPH – Childrens National Hospital
### @@@ Leah Mendelsohn Stone, JD – Association for the Advancement of Blood and Biotherapies ### 2362154###Speaker###Vice President, Public Policy and Advocacy###Association for the Advancement of Blood and Biotherapies###
Speaker: Leah Mendelsohn Stone, JD – Association for the Advancement of Blood and Biotherapies
### AM24-MN-36-L
G
Gender-Specific Individual Donor Assessment (IDA) based Deferral Rates as Compared to MSM Based Deferral in a Large US Blood Collection Establishment (OA1-AM24-TU-07)
Favorite

Ruchika Goel, MD, MPH, CABP (she/her/hers) – Vitalant and Johns Hopkins University ### 2362125###Presenting Author###Senior Medical Director, Corporate Medical Affairs. Professor of Internal Medicine and Pediatrics###Vitalant and Johns Hopkins University###
Presenting Author: Ruchika Goel, MD, MPH, CABP (she/her/hers) – Vitalant and Johns Hopkins University
### she/her/hers OA1-AM24-TU-07
Generation and Characterization of Megakaryocytes that Producing Platelets Derived from Cord Blood (OA3-AM24-TU-06)
Favorite

Y M He, MD (she/her/hers) – Blood Center of Zhejiang Province ### 2119578###Presenting Author######Blood Center of Zhejiang Province###
Presenting Author: Y M He, MD (she/her/hers) – Blood Center of Zhejiang Province
### she/her/hers OA3-AM24-TU-06
Genetic Determinants of Plasma Testosterone in Male Blood Donors Impact Red Blood Cell Characteristics and Survival in Cold Storage and After Transfusion (OA4-AM24-ST-17)
Favorite

Tamir Kanias, PhD – Vitalant Research Institute ### 2119451###Presenting Author###Associate Investigator###Vitalant Research Institute###
Presenting Author: Tamir Kanias, PhD – Vitalant Research Institute
### OA4-AM24-ST-17
Genetic Engineering of Megakaryocytes From Blood Progenitor Cells Using mRNA Lipid Nanoparticles (PL5-SN-27)
Favorite

Jerry Leung, PhD (he/him/his) – University of British Columbia ### 1762739###Presenting Author###Postdoctoral Research Fellow###University of British Columbia###
Presenting Author: Jerry Leung, PhD (he/him/his) – University of British Columbia
### he/him/his PL5-SN-27
H
Healthcare Burden And Factors Associated With Re-admission Among Patients with Sickle Cell Disease in the United States: Insights From a Nationally Representative Database (OA1-AM24-MN-39)
Favorite

Ruchika Goel, MD, MPH, CABP (she/her/hers) – Vitalant and Johns Hopkins University ### 2362125###Presenting Author###Senior Medical Director, Corporate Medical Affairs. Professor of Internal Medicine and Pediatrics###Vitalant and Johns Hopkins University###
Presenting Author: Ruchika Goel, MD, MPH, CABP (she/her/hers) – Vitalant and Johns Hopkins University
### she/her/hers OA1-AM24-MN-39
Hemorrhage Control and Resuscitation: New Tools. (AM24-MN-37-L)
Favorite

John R. Hess, MD, MD, MPH, FACP, FAAAS – University of Washington School of Medicine ### 832985###Program Chair###Professor of Laboratory Medicine and Pathology, Medicine and Hematology###University of Washington School of Medicine###
Program Chair: John R. Hess, MD, MD, MPH, FACP, FAAAS – University of Washington School of Medicine
### @@@ Srinivasa R. Raghavan, PhD – University of Maryland, College Park ### 2362123###Speaker###Professor of Chemical & Biomolecular Engineering###University of Maryland, College Park###
Speaker: Srinivasa R. Raghavan, PhD – University of Maryland, College Park
### @@@ Jose Cancelas, MD, PhD (he/him/his) – Dana-Farber Cancer Institute, Harvard Medical School ### 837000###Speaker###Executive Director, Connell and O'Reilly Families Cell Manipulation Core Facility###Dana-Farber Cancer Institute, Harvard Medical School###
Speaker: Jose Cancelas, MD, PhD (he/him/his) – Dana-Farber Cancer Institute, Harvard Medical School
### he/him/his AM24-MN-37-L
HHV-8 Seroprevalence Among Blood Donors in Uganda (OA2-AM24-ST-06)
Favorite

Tait H. Huso, MD – Johns Hopkins University School of Medicine ### 2418310###Presenting Author######Johns Hopkins University School of Medicine###
Presenting Author: Tait H. Huso, MD – Johns Hopkins University School of Medicine
### OA2-AM24-ST-06
HIV, HBV, and HCV Prevalence, Incidence, and Residual Risk in US Blood Donors, 2015-2023 (OA3-AM24-ST-06)
Favorite

Emilya Huseynova, MD, MPH (she/her/hers) – The American Red Cross ### 2418099###Presenting Author###Principal Clinical Research Scientist###The American Red Cross###
Presenting Author: Emilya Huseynova, MD, MPH (she/her/hers) – The American Red Cross
### she/her/hers OA3-AM24-ST-06
HLA Alloimmunization in ReCePI, a Phase III Study of Amustaline/Glutathione Pathogen Reduced RBCs (OA1-AM24-MN-23)
Favorite

Philip Norris, MD – Vitalant Research Institute ### 2117890###Presenting Author###VP Research###Vitalant Research Institute###
Presenting Author: Philip Norris, MD – Vitalant Research Institute
### OA1-AM24-MN-23
Humoral Response to Antigen Challenge in Plasmapheresis Donors with Different Circulating IgG Levels (OA1-AM24-SN-12)
Favorite

Renee Bazin, PhD (she/her/hers) – Hema-Quebec ### 1800135###Presenting Author######Hema-Quebec###
Presenting Author: Renee Bazin, PhD (she/her/hers) – Hema-Quebec
### she/her/hers OA1-AM24-SN-12
I
Impact Of P38 Mitogen Activated Protein Kinase And Minocycline On Platelets Stored At Cold Temperature For 21 Days (OA4-AM24-MN-14)
Favorite

Andrey Skripchenko, PhD (he/him/his) – FDA ### 2118422###Presenting Author###Biological Reviewer###FDA###
Presenting Author: Andrey Skripchenko, PhD (he/him/his) – FDA
### he/him/his OA4-AM24-MN-14
Implementation of Individual Donor Assessment in the USA and Impact on Rates of Residual Infectious Disease (PL6-SN-27)
Favorite

Mary Townsend, MD (she/her/hers) – Vitalant ### 2118747###Presenting Author###Vice President, Corporate Medical Director###Vitalant###
Presenting Author: Mary Townsend, MD (she/her/hers) – Vitalant
### she/her/hers PL6-SN-27
Implementation of Sexual Risk Behaviour Donor Screening (OA2-AM24-TU-07)
Favorite

Mindy Goldman, MD, FRCPC (she/her/hers) – Canadian Blood Services ### 2118683###Presenting Author###Medical Director###Canadian Blood Services###
Presenting Author: Mindy Goldman, MD, FRCPC (she/her/hers) – Canadian Blood Services
### she/her/hers OA2-AM24-TU-07
In Limbo with ABO: The Type Discrepancies You’re Probably Seeing But No One is Talking About (AM24-MN-24-L)
Favorite

Rebecca Coward, MLS (ASCP), SBB – WakeMed ### 837477###Speaker###Supervisor, Transfusion Service###WakeMed ###
Speaker: Rebecca Coward, MLS (ASCP), SBB – WakeMed
### @@@ Madeline Konicek, MLS(ASCP)SBB (she/her/hers) – Versiti Wisconsin ### 2362129###Speaker###Senior Scientist, Immunohematology Reference Lab###Versiti Wisconsin###
Speaker: Madeline Konicek, MLS(ASCP)SBB (she/her/hers) – Versiti Wisconsin
### she/her/hers @@@ Elizabeth S. Allen, MD – University of California San Diego ### 2038670###Program Chair###Associate Professor of Pathology###University of California San Diego###
Program Chair: Elizabeth S. Allen, MD – University of California San Diego
### AM24-MN-24-L
In Vitro Quality of RBCs in PAGGS-M Prepared in Non-DEHP Bag Systems: Influence of Weekly Mixing (OA2-AM24-ST-13)
Favorite

Ute Gravemann, PhD (she/her/hers) – German Red Cross Blood Service NSTOB ### 2418242###Presenting Author######German Red Cross Blood Service NSTOB###
Presenting Author: Ute Gravemann, PhD (she/her/hers) – German Red Cross Blood Service NSTOB
### she/her/hers OA2-AM24-ST-13
Incidence and Prevalence of Red Blood Cell Antibodies and Their Clinical Implications in Allogeneic Hematopoietic Stem Cell Transplantation: A BEST Collaborative Study (OA4-AM24-MN-15)
Favorite

Valery Kogler, MD – University of Virginia Health ### 2418128###Presenting Author######University of Virginia Health###
Presenting Author: Valery Kogler, MD – University of Virginia Health
### OA4-AM24-MN-15
Inflammatory Profile Among Kidney Donors with HIV and Without HIV to Recipients with HIV (OA4-AM24-ST-06)
Favorite

Fatima Zaman, MBBS, MPH, MMSc (she/her/hers) – Johns Hopkins University ### 2418258###Presenting Author######Johns Hopkins University###
Presenting Author: Fatima Zaman, MBBS, MPH, MMSc (she/her/hers) – Johns Hopkins University
### she/her/hers OA4-AM24-ST-06
Innovation and Challenges in Donor Recruitment (AM24-MN-16-L)
Favorite

Elizabeth Hartwell, MD – Gulf Coast Regional Blood Center ### 2362134###Program Chair###Chief Medical Officer###Gulf Coast Regional Blood Center###
Program Chair: Elizabeth Hartwell, MD – Gulf Coast Regional Blood Center
### @@@ Brian Bautista – Versiti ### 2502319###Speaker###Chief Operating Officer & EVP###Versiti###
Speaker: Brian Bautista – Versiti
### @@@ Hunter Shaffer, MBA – Blood Centers of America (BCA) ### 2117964###Speaker###Sr. Director, Strategic Advisor###Blood Centers of America (BCA)###
Speaker: Hunter Shaffer, MBA – Blood Centers of America (BCA)
### AM24-MN-16-L
Innovation in Transfusion: How Creative Partnerships are Improving the Care of Critically Ill Trauma Patients (AM24-MN-29-L)

Favorite

Randi Schaefer, DNP, RN, ACNS-BC, CEN – Schaefer Consulting ### 2362179###Program Chair###CEO###Schaefer Consulting###
Program Chair: Randi Schaefer, DNP, RN, ACNS-BC, CEN – Schaefer Consulting
### @@@ Warren Christina, MSHS,MLS(ASCP)SBB – Atrium Health Wake Forest Baptist ### 2362181###Speaker###Laboratory Medicine Manager, Blood Bank and Stem Cell Transplant Cellular Therapies###Atrium Health Wake Forest Baptist###
Speaker: Warren Christina, MSHS,MLS(ASCP)SBB – Atrium Health Wake Forest Baptist
### @@@ Tom Dransfield, NRP (he/him/his) – New Orleans EMS ### 2379971###Speaker###Major - Quality Assurance and Safety Officer###New Orleans EMS###
Speaker: Tom Dransfield, NRP (he/him/his) – New Orleans EMS
### he/him/his @@@ Mark Piehl, MD, MPH – WakeMed ### 2438388###Speaker###Medical Director, WakeMed Children's Mobile Critical Care###WakeMed###
Speaker: Mark Piehl, MD, MPH – WakeMed
### AM24-MN-29-L
Insights from Mixed Methods Analysis of the ADVANCE Study: Appropriate Donation Educational Materials Remain Critical (OA3-AM24-ST-27)
Favorite

Shana D. Hughes, PhD (she/her/hers) – Vitalant Research Institute ### 1765612###Presenting Author######Vitalant Research Institute###
Presenting Author: Shana D. Hughes, PhD (she/her/hers) – Vitalant Research Institute
### she/her/hers OA3-AM24-ST-27
IRL Accreditation: Helpful Hints and Case Studies for Better Conformance (AM24-MN-40-L)
Favorite

Paul Mansfield, MLS(ASCP)SBB – American Red Cross ### 833235###Program Chair###Director, IRL###American Red Cross###
Program Chair: Paul Mansfield, MLS(ASCP)SBB – American Red Cross
### @@@ Janis R. Hamilton, MS, MLS(ASCP)SBB – American Red Cross ### 1762704###Speaker###Manager, IRL###American Red Cross###
Speaker: Janis R. Hamilton, MS, MLS(ASCP)SBB – American Red Cross
### @@@ Thierry Peyrard, PharmD, PhD, European Specialist in Laboratory Medicine (he/him/his) – French Blood Establishment (EFS), Paris, France; University of Paris Cité and University of Antilles, INSERM, BIGR ### 837197###Speaker###Director of the National Reference Department of Immunohematology and Rare Blood###French Blood Establishment (EFS), Paris, France; University of Paris Cité and University of Antilles, INSERM, BIGR###
Speaker: Thierry Peyrard, PharmD, PhD, European Specialist in Laboratory Medicine (he/him/his) – French Blood Establishment (EFS), Paris, France; University of Paris Cité and University of Antilles, INSERM, BIGR
### he/him/his @@@ Claribel Resto, MLS(ASCP) SBB – OneBlood ### 2362189###Speaker###Director, Immunohematology Reference Laboratories###OneBlood###
Speaker: Claribel Resto, MLS(ASCP) SBB – OneBlood
### @@@ Marisela G. Marchan, MSTM, MLS(ASCP)SBBcm (she/her/hers) – Versiti ### 837541###Speaker###Manager, Platelet, Neutrophil Immunology Laboratory###Versiti###
Speaker: Marisela G. Marchan, MSTM, MLS(ASCP)SBBcm (she/her/hers) – Versiti
### she/her/hers @@@ Karen Milks, MLS(ASCP)SBB CM – Alba Biosciences ### 2447225###Speaker###Technical Support Lead###Alba Biosciences###
Speaker: Karen Milks, MLS(ASCP)SBB CM – Alba Biosciences
### @@@ Yoon Hlas, MLS(ASCP)SBB (she/her/hers) – Vitalant Laboratories ### 2447226###Speaker###IRL###Vitalant Laboratories###
Speaker: Yoon Hlas, MLS(ASCP)SBB (she/her/hers) – Vitalant Laboratories
### she/her/hers AM24-MN-40-L
Is Your Firm Ready for an FDA Office of Inspections and Investigations Inspection? Hear about the Most Frequently Cited Observations and Inspectional Process from FDA’s Office of Biologics Inspectorate (AM24-TU-10-L)
Favorite

Tricia Samaniego Martinez – US Food and Drug Administration ### 885961###Program Chair###Senior Advisor###US Food and Drug Administration###
Program Chair: Tricia Samaniego Martinez – US Food and Drug Administration
### @@@ Scott Ballard, MS, CABP – US Food and Drug Administration ### 1762750###Speaker###National Expert Investigator###US Food and Drug Administration###
Speaker: Scott Ballard, MS, CABP – US Food and Drug Administration
### @@@ Laurissa Flowers – US Food and Drug Administration ### 2362130###Speaker###Biologics National Expert Investigator###US Food and Drug Administration###
Speaker: Laurissa Flowers – US Food and Drug Administration
### AM24-TU-10-L
L
Laboratory Clinicians and Transfusion Medicine Specialist at the Center of Patient Safety (AM24-ST-02-L)

Favorite

Marisa Saint Martin, MD, ACC – Loyola University Medical Center ### 2362186###Program Chair###Affiliate Associate Professor###Loyola University Medical Center###
Program Chair: Marisa Saint Martin, MD, ACC – Loyola University Medical Center
### @@@ Kimberly Klein, MD – M.D. Anderson Cancer Center ### 2118978###Speaker###Medical Director of the Hemovigilance Unit###M.D. Anderson Cancer Center###
Speaker: Kimberly Klein, MD – M.D. Anderson Cancer Center
### @@@ James Kelley, MD, PhD – OneOme ### 2362167###Speaker###Chief Medical Officer###OneOme###
Speaker: James Kelley, MD, PhD – OneOme
### AM24-ST-02-L
Lesson's Learned Onboarding Cell and Gene Therapy Vendors and Clients in the 21st Century (AM24-SN-09-L)

Favorite

Kevin J. Land, MD – Vitalant ### 837509###Program Chair###VP Clinical Services###Vitalant###
Program Chair: Kevin J. Land, MD – Vitalant
### @@@ Melissa Marlowe, CHS, MBA – Vitalant ### 2362168###Speaker###VP Clinical Services Adminstration###Vitalant###
Speaker: Melissa Marlowe, CHS, MBA – Vitalant
### @@@ Kate Brown, PhD (she/they) – CooperSurgical, Inc. ### 1762686###Speaker###Senior Director of Science###CooperSurgical, Inc.###
Speaker: Kate Brown, PhD (she/they) – CooperSurgical, Inc.
### she/they @@@ Laura Staller, MHA, MLS(ASCP) – NMDP ### 2508963###Speaker###Manager###NMDP###
Speaker: Laura Staller, MHA, MLS(ASCP) – NMDP
### @@@ Robert Marriott – Vitalant ### 2508964###Speaker###Vice President###Vitalant###
Speaker: Robert Marriott – Vitalant
### AM24-SN-09-L
Lord of the Antibodies (AM24-TU-12-L)

Favorite

Jasem M. Albasri, MSTM, SBB(ASCP)CM – Prince Sultan Military Medical City ### 2362135###Speaker###Blood Bank Supervisor###Prince Sultan Military Medical City###
Speaker: Jasem M. Albasri, MSTM, SBB(ASCP)CM – Prince Sultan Military Medical City
### @@@ Andie Pahomi, MSTM, MLS(ASCP)CMSBBCM (she/her/hers) – Versiti ### 2362136###Speaker###Manager, Immunohematology Reference Laboratory###Versiti###
Speaker: Andie Pahomi, MSTM, MLS(ASCP)CMSBBCM (she/her/hers) – Versiti
### she/her/hers @@@ Sue T. Johnson, MSTM, MLS(ASCP)SBBCM – Versiti ### 1762728###Program Chair###Director, Clinical Education###Versiti###
Program Chair: Sue T. Johnson, MSTM, MLS(ASCP)SBBCM – Versiti
### AM24-TU-12-L
Lyophilized, Stem-cell Derived, and Synthetic Platelet Products are Closer Than You May Think. (AM24-MN-32-L)
Favorite

Claudia Cohn, MD, Phd – University of Minnesota ### 2362155###Program Chair###Professor of Laboratory Medicine and Pathology, Dir. Blood Bank Lab., Ass. Dir. Clinical Lab.###University of Minnesota###
Program Chair: Claudia Cohn, MD, Phd – University of Minnesota
### @@@ Anirban Sen Gupta, PhD (he/him/his) – Case Western Reserve University ### 2362156###Speaker###Wallace R. Persons Endowed Professor of Engineering, Professor Biomedical Engineering, Director: Bio-inspired Engineering for Advanced Therapies (BEAT) Laboratory###Case Western Reserve University###
Speaker: Anirban Sen Gupta, PhD (he/him/his) – Case Western Reserve University
### he/him/his @@@ Cedric Ghevaert, MD, PhD, FRCP, FRCPath (he/him/his) – University of Cambridge / NHS Blood and Transplant ### 2362157###Speaker###Professor of Transfusion Medicine and Consultant Haematologist###University of Cambridge / NHS Blood and Transplant###
Speaker: Cedric Ghevaert, MD, PhD, FRCP, FRCPath (he/him/his) – University of Cambridge / NHS Blood and Transplant
### he/him/his @@@ Mike Fitzpatrick, PhD – Cellphire, Inc ### 837619###Speaker###Chief Scientific Officer (CSO)###Cellphire, Inc###
Speaker: Mike Fitzpatrick, PhD – Cellphire, Inc
### AM24-MN-32-L
M
Machine Learning Versus Traditional Regression Analytics to Study the Association between Peri-Operative Red Blood Cell Transfusions and Venous Thromboembolism (OA2-AM24-MN-08)
Favorite

Ruchika Goel, MD, MPH, CABP (she/her/hers) – Vitalant and Johns Hopkins University ### 2362125###Presenting Author###Senior Medical Director, Corporate Medical Affairs. Professor of Internal Medicine and Pediatrics###Vitalant and Johns Hopkins University###
Presenting Author: Ruchika Goel, MD, MPH, CABP (she/her/hers) – Vitalant and Johns Hopkins University
### she/her/hers OA2-AM24-MN-08
Making Learning Stick – Effective Training for Blood and Biotherapies Professionals (AM24-MN-17-L)
Favorite

Jaime McGillivray (she/her/hers) – Canadian Management Centre ### 2477438###Program Chair###Director of Leadership and Performance###Canadian Management Centre###
Program Chair: Jaime McGillivray (she/her/hers) – Canadian Management Centre
### she/her/hers @@@ Jamie Li, MA (she/her/hers) – Canadian Management Centre (CMC) ### 2480636###Speaker###Senior Learning Experience Manager###Canadian Management Centre (CMC)###
Speaker: Jamie Li, MA (she/her/hers) – Canadian Management Centre (CMC)
### she/her/hers AM24-MN-17-L
Management of Hematotoxicity from Immune Effector Cell Therapy and Sickle Cell Disease Gene Therapy (AM24-MN-09-L)
Favorite

Patricia Shi, MD (she/her/hers) – New York Blood Center ### 833582###Program Chair###Medical Director, Vice President###New York Blood Center###
Program Chair: Patricia Shi, MD (she/her/hers) – New York Blood Center
### she/her/hers @@@ Alexis Leonard, MD (she/her/hers) – St. Jude Children's Research Hospital ### 2420861###Speaker###Assistant Member###St. Jude Children's Research Hospital###
Speaker: Alexis Leonard, MD (she/her/hers) – St. Jude Children's Research Hospital
### she/her/hers @@@ Sara K. Silbert, MD, M.H.Sc (she/her/hers) – NIH ### 2433638###Speaker###Assistant Research Physician###NIH###
Speaker: Sara K. Silbert, MD, M.H.Sc (she/her/hers) – NIH
### she/her/hers AM24-MN-09-L
Managing Risk, Maximizing Safety: The Essentials of Proactive Risk Assessment (AM24-TU-11-L)
Favorite

Faisal Alsaqri, MSc, CLBSSB – King Abdulaziz Medical City -Riyadh ### 2362162###Program Chair###Laboratry Operations and quality Improvment analyst###King Abdulaziz Medical City -Riyadh###
Program Chair: Faisal Alsaqri, MSc, CLBSSB – King Abdulaziz Medical City -Riyadh
### @@@ Faisal Alsaqri, MSc, CLBSSB – King Abdulaziz Medical City -Riyadh ### 2362162###Speaker###Laboratry Operations and quality Improvment analyst###King Abdulaziz Medical City -Riyadh###
Speaker: Faisal Alsaqri, MSc, CLBSSB – King Abdulaziz Medical City -Riyadh
### @@@ Hillary Brown, BS, MLT (she/her/hers) – Massachusetts General Hospital Cellular Therapy Lab (CTTL) ### 2038691###Speaker###Compliance Specialist CTTL###Massachusetts General Hospital Cellular Therapy Lab (CTTL)###
Speaker: Hillary Brown, BS, MLT (she/her/hers) – Massachusetts General Hospital Cellular Therapy Lab (CTTL)
### she/her/hers AM24-TU-11-L
Mechanisms and Technologies Towards Expanding Hematopoietic Stem Cells for Transplantation (AM24-MN-34-L)
Favorite

Larry Luchsinger, PhD – New York Blood Center ### 1762746###Program Chair###Associate Member, SVP and Chief Scientific Officer###New York Blood Center###
Program Chair: Larry Luchsinger, PhD – New York Blood Center
### @@@ Colleen Delaney, MD, MSc (she/her/hers) – Deverra Therapeutics ### 2438382###Speaker###Founder and Chief Scientific Officer###Deverra Therapeutics###
Speaker: Colleen Delaney, MD, MSc (she/her/hers) – Deverra Therapeutics
### she/her/hers @@@ Adam Wilkinson, PhD (he/him/his) – University of Oxford ### 2475747###Speaker###Associate Professor Of Stem Cell Biology###University of Oxford###
Speaker: Adam Wilkinson, PhD (he/him/his) – University of Oxford
### he/him/his AM24-MN-34-L
Mechanisms of Hematopoietic Stem Cells Towards Rejuvenation of the Aging Hematopoietic System (AM24-MN-18-L)
Favorite

Ying Liang, PhD/MD (she/her/hers) – Lindsley F. Kimball Research Institute, NYBC ### 2362185###Program Chair###Member (Professor)###Lindsley F. Kimball Research Institute, NYBC###
Program Chair: Ying Liang, PhD/MD (she/her/hers) – Lindsley F. Kimball Research Institute, NYBC
### she/her/hers @@@ Katherine King, MD, PhD (she/her/hers) – Baylor College of Medicine ### 2410524###Speaker###Professor###Baylor College of Medicine###
Speaker: Katherine King, MD, PhD (she/her/hers) – Baylor College of Medicine
### she/her/hers @@@ Marie-Dominique Filippi, PhD (she/her/hers) – Cincinnati Children's Hospital Research Foundation ### 2411530###Speaker###Professor Stem Cell Program Leader Director, Comprehensive Mouse and Cancer Core Professor###Cincinnati Children's Hospital Research Foundation###
Speaker: Marie-Dominique Filippi, PhD (she/her/hers) – Cincinnati Children's Hospital Research Foundation
### she/her/hers AM24-MN-18-L
Microfluidic Leukapheresis is Safe and Effective in a Rat Model (OA2-AM24-TU-14)
Favorite

Sergey S. Shevkoplyas, PhD – University of Houston ### 2418247###Presenting Author###Professor of Biomedical Engineering###University of Houston###
Presenting Author: Sergey S. Shevkoplyas, PhD – University of Houston
### OA2-AM24-TU-14
Multidisciplinary Massive Transfusion Protocol Simulations: Updates and Best Practices in Simulation Science (AM24-ST-25-L)
Favorite

TRISHA WONG, MD, MS (she/her/hers) – Oregon Health Sciences University, Portland, OR ### 2038727###Program Chair###Assistant Medical Director of Transfusion Services###Oregon Health Sciences University, Portland, OR###
Program Chair: TRISHA WONG, MD, MS (she/her/hers) – Oregon Health Sciences University, Portland, OR
### she/her/hers @@@ TRISHA WONG, MD, MS (she/her/hers) – Oregon Health Sciences University, Portland, OR ### 2038727###Speaker###Assistant Medical Director of Transfusion Services###Oregon Health Sciences University, Portland, OR###
Speaker: TRISHA WONG, MD, MS (she/her/hers) – Oregon Health Sciences University, Portland, OR
### she/her/hers @@@ Michelle Brown, PhD, MS, MLS(ASCP) SBB (she/her/hers) – The University of Alabama at Birmingham ### 2406471###Speaker###Associate Professor and Director###The University of Alabama at Birmingham###
Speaker: Michelle Brown, PhD, MS, MLS(ASCP) SBB (she/her/hers) – The University of Alabama at Birmingham
### she/her/hers AM24-ST-25-L
N
New Directions in Coagulation Management and Transfusion Practice with Viscoelastic Testing in the OR (AM24-SN-02-L)

Favorite

Timothy C. Carll, MD (he/him/his) – University of Chicago ### 2362144###Speaker###Assistant Professor, Pathology / Transfusion, Hemostasis, & Apheresis Medicine###University of Chicago###
Speaker: Timothy C. Carll, MD (he/him/his) – University of Chicago
### he/him/his @@@ Katherine Forkin, MD (she/her/hers) – University of Virginia ### 2362145###Speaker###Liver Transplant Anesthesiology Division Chief, Associate Professor of Anesthesiology###University of Virginia###
Speaker: Katherine Forkin, MD (she/her/hers) – University of Virginia
### she/her/hers @@@ Zhen W. Mei, MD – David Geffen School of Medicine at University of California Los Angeles ### 2118763###Program Chair###Health Sciences Assistant Clinical Professor###David Geffen School of Medicine at University of California Los Angeles###
Program Chair: Zhen W. Mei, MD – David Geffen School of Medicine at University of California Los Angeles
### AM24-SN-02-L
No Evidence of Anti-D Alloimmunization After RhD-Positive Apheresis Platelet Transfusion to RhD-Negative Pediatric, Adolescent and Young Adults without RhIg Prophylaxis (OA3-AM24-MN-07)
Favorite

Kristina Prus, MD (she/her/hers) – Cincinnati Children's Hospital Medical Center ### 2418362###Presenting Author###Director of Transfusion Services, Section Director of Clinical Coagulation Testing Laboratory, Medical Director of the Cellular Manipulation Laboratory###Cincinnati Children's Hospital Medical Center###
Presenting Author: Kristina Prus, MD (she/her/hers) – Cincinnati Children's Hospital Medical Center
### she/her/hers OA3-AM24-MN-07
Novel Anticoagulant/Additive Solution Maintains the Hemostatic Function of Cold Stored Whole Blood for 56 Days (OA3-AM24-SN-23)
Favorite

Jose Cancelas, MD, PhD (he/him/his) – Dana-Farber Cancer Institute, Harvard Medical School ### 837000###Presenting Author###Executive Director, Connell and O'Reilly Families Cell Manipulation Core Facility###Dana-Farber Cancer Institute, Harvard Medical School###
Presenting Author: Jose Cancelas, MD, PhD (he/him/his) – Dana-Farber Cancer Institute, Harvard Medical School
### he/him/his OA3-AM24-SN-23
O
Operationalizing Delivery of Gene Therapy for Sickle Cell Disease (AM24-SN-06-L)
Favorite

Stella Chou, MD (she/her/hers) – Children's Hospital of Philadelphia, University of Pennsylvania ### 2119648###Speaker###Chief, Division of Transfusion Medicine###Children's Hospital of Philadelphia, University of Pennsylvania###
Speaker: Stella Chou, MD (she/her/hers) – Children's Hospital of Philadelphia, University of Pennsylvania
### she/her/hers @@@ Yan Zheng, MD/PhD (she/her/hers) – St. Jude Children's Research Hospital ### 2119494###Speaker###Associate Member###St. Jude Children's Research Hospital###
Speaker: Yan Zheng, MD/PhD (she/her/hers) – St. Jude Children's Research Hospital
### she/her/hers @@@ Janet Kwiatkowski, MD, MSCE – CHOP ### 2418805###Speaker###Director###CHOP###
Speaker: Janet Kwiatkowski, MD, MSCE – CHOP
### @@@ Ryan A. Metcalf, MD – ARUP Labs and Utah School of Medicine ### 1762752###Program Chair###Section Chief, Transfusion Medicine###ARUP Labs and Utah School of Medicine###
Program Chair: Ryan A. Metcalf, MD – ARUP Labs and Utah School of Medicine
### AM24-SN-06-L
Oral Abstract - COVID (AM24-ST-26-L)
Favorite

Mike Busch, MD, PhD (he/him/his) – Vitalant Research Institute ### 2042503###Program Chair###Director Emeritus###Vitalant Research Institute###
Program Chair: Mike Busch, MD, PhD (he/him/his) – Vitalant Research Institute
### he/him/his @@@ Freddy Nguyen, MD, PhD – Fellow - MIT ### 2482880###Program Chair###CEO, Co-Founder - Nine Diagnostics###Fellow - MIT###
Program Chair: Freddy Nguyen, MD, PhD – Fellow - MIT
### AM24-ST-26-L
Oral Abstract - Genomics (AM24-TU-15-L)
Favorite

Margaret A. Keller, PhD (she/her/hers) – American Red Cross ### 832938###Program Chair###Executive, National Laboratories Senior Director, American Rare Donor Program American Red Cross###American Red Cross###
Program Chair: Margaret A. Keller, PhD (she/her/hers) – American Red Cross
### she/her/hers @@@ Patricia Brunker, MD, DPhil (she/her/hers) – Massachusetts General Hospital ### 2419538###Program Chair###Medical Director, Blood Transfusion Service Patient Services###Massachusetts General Hospital###
Program Chair: Patricia Brunker, MD, DPhil (she/her/hers) – Massachusetts General Hospital
### she/her/hers AM24-TU-15-L
Oral Abstract - Biotherapy Spotlight (AM24-TU-06-L)
Favorite

David Stroncek, MD – National Institutes of Health ### 837205###Program Chair######National Institutes of Health###
Program Chair: David Stroncek, MD – National Institutes of Health
### AM24-TU-06-L
Oral Abstract - Blood Donor Issues (AM24-ST-17-L)
Favorite

Eric Senaldi – New York Blood Center ### 869654###Program Chair###Deputy Chief Medical Officer###New York Blood Center###
Program Chair: Eric Senaldi – New York Blood Center
### @@@ Gwendolyn Jones – Vitalant ### 2481013###Program Chair###Vice President###Vitalant###
Program Chair: Gwendolyn Jones – Vitalant
### AM24-ST-17-L
Oral Abstract - Blood Donor Testing (AM24-SN-12-L)
Favorite

Jean Stanley, MBA, MLS(ASCP)SBB, CMQ/OE(ASQ)CQA – Roche Diagnostics Solutions ### 2419007###Program Chair######Roche Diagnostics Solutions###
Program Chair: Jean Stanley, MBA, MLS(ASCP)SBB, CMQ/OE(ASQ)CQA – Roche Diagnostics Solutions
### @@@ Rim Abdallah, MD – Vitalant ### 2418973###Program Chair######Vitalant###
Program Chair: Rim Abdallah, MD – Vitalant
### AM24-SN-12-L
Oral Abstract - Blood Safety Evaluation (AM24-ST-27-L)
Favorite

Philip Norris, MD – Vitalant Research Institute ### 2117890###Program Chair###VP Research###Vitalant Research Institute###
Program Chair: Philip Norris, MD – Vitalant Research Institute
### @@@ Emily Coberly, MD – American Red Cross ### 2038664###Program Chair###Divisional Chief Medical Officer###American Red Cross###
Program Chair: Emily Coberly, MD – American Red Cross
### AM24-ST-27-L
Oral Abstract - Clinical Transfusion Medicine (AM24-MN-39-L)
Favorite

Mary Berg – University of Colorado ### 832665###Program Chair######University of Colorado###
Program Chair: Mary Berg – University of Colorado
### @@@ Beth S. Raju, M.D. – Mount Sinai Hospital / Icahn School of Medicine ### 2419352###Program Chair######Mount Sinai Hospital / Icahn School of Medicine###
Program Chair: Beth S. Raju, M.D. – Mount Sinai Hospital / Icahn School of Medicine
### AM24-MN-39-L
Oral Abstract - Donor Adverse Events (AM24-SN-15-L)
Favorite

Todd Nishimoto, MD – Blood Bank of Hawaii ### 2418484###Program Chair######Blood Bank of Hawaii###
Program Chair: Todd Nishimoto, MD – Blood Bank of Hawaii
### @@@ Sarah Vossoughi, MD, RN (she/her/hers) – New York Blood Center Enterprises ### 2418759###Program Chair######New York Blood Center Enterprises###
Program Chair: Sarah Vossoughi, MD, RN (she/her/hers) – New York Blood Center Enterprises
### she/her/hers AM24-SN-15-L
Oral Abstract - Immunohematology (AM24-ST-19-L)
Favorite

Kathy Haddaway, MLS(ASCP)CMSBBCM – Johns Hopkins Hospital ### 1762673###Program Chair###Technical Specialist II###Johns Hopkins Hospital###
Program Chair: Kathy Haddaway, MLS(ASCP)CMSBBCM – Johns Hopkins Hospital
### @@@ Tony S. Casina, CLS(ASCP)SBB – Independent Consultant - TSC Consulting ### 2118252###Program Chair######Independent Consultant - TSC Consulting###
Program Chair: Tony S. Casina, CLS(ASCP)SBB – Independent Consultant - TSC Consulting
### AM24-ST-19-L
Oral Abstract - Infectious Diseases, Viruses (AM24-ST-06-L)
Favorite

Ralph R. Vassallo, MD FACP – Vitalant ### 2419098###Program Chair###EVP / Chief Medical & Scientific Officer###Vitalant###
Program Chair: Ralph R. Vassallo, MD FACP – Vitalant
### @@@ Tobias Cohen, MD, PhD (he/him/his) – Weill Cornell Medicine ### 2135760###Program Chair###Assistant Director of Transfusion Medicine and Cellular Biotherapies###Weill Cornell Medicine###
Program Chair: Tobias Cohen, MD, PhD (he/him/his) – Weill Cornell Medicine
### he/him/his AM24-ST-06-L
Oral Abstract - Mouse Models (AM24-TU-14-L)
Favorite

Elizabeth Stone, MD, PhD – Columbia University Irving Medical Center ### 1762674###Program Chair###Assistant Professor of Pathology & Cell Biology###Columbia University Irving Medical Center###
Program Chair: Elizabeth Stone, MD, PhD – Columbia University Irving Medical Center
### @@@ Chance J. Luckey, MD,PhD (he/him/his) – University of Virginia ### 2119131###Program Chair######University of Virginia###
Program Chair: Chance J. Luckey, MD,PhD (he/him/his) – University of Virginia
### he/him/his AM24-TU-14-L
Oral Abstract - Pathogen reduction (AM24-MN-23-L)
Favorite

Andrea McGonigle – Associate Medical Director, Division of Transfusion Medicine, Department of Pathology and Laboratory Medicine, UCLA Health System ### 833811###Program Chair######Associate Medical Director, Division of Transfusion Medicine, Department of Pathology and Laboratory Medicine, UCLA Health System###
Program Chair: Andrea McGonigle – Associate Medical Director, Division of Transfusion Medicine, Department of Pathology and Laboratory Medicine, UCLA Health System
### @@@ Edward S. Lee, MD, PhD (he/him/his) – Yale School of Medicine ### 1765743###Program Chair######Yale School of Medicine###
Program Chair: Edward S. Lee, MD, PhD (he/him/his) – Yale School of Medicine
### he/him/his AM24-MN-23-L
Oral Abstract - Patient Blood Management (AM24-MN-08-L)
Favorite

Richard R. Gammon, MD – Carter BloodCare ### 832453###Program Chair###Chief Medical Officer###Carter BloodCare###
Program Chair: Richard R. Gammon, MD – Carter BloodCare
### @@@ Alexandra Jimenez, MD – New York Blood Center ### 837483###Program Chair###Director of Transfusion Medicine Education, Associate Director of Transfusion Medicine and Cellular Therapy###New York Blood Center###
Program Chair: Alexandra Jimenez, MD – New York Blood Center
### AM24-MN-08-L
Oral Abstract - Pediatrics (AM24-MN-07-L)
Favorite

Stella Chou, MD (she/her/hers) – Children's Hospital of Philadelphia, University of Pennsylvania ### 2119648###Program Chair###Chief, Division of Transfusion Medicine###Children's Hospital of Philadelphia, University of Pennsylvania###
Program Chair: Stella Chou, MD (she/her/hers) – Children's Hospital of Philadelphia, University of Pennsylvania
### she/her/hers @@@ Nabiha Saifee, MD PhD – Seattle Children's Hospital ### 1762662###Program Chair###Assistant Professor, Transfusion Service Medical Director###Seattle Children's Hospital###
Program Chair: Nabiha Saifee, MD PhD – Seattle Children's Hospital
### AM24-MN-07-L
Oral Abstract - Platelet Storage (AM24-MN-14-L)
Favorite

Andrew Cap, MS, MD, PhD (he/him/his) – U.S. Army Institute of Surgical Research ### 2118937###Program Chair######U.S. Army Institute of Surgical Research###
Program Chair: Andrew Cap, MS, MD, PhD (he/him/his) – U.S. Army Institute of Surgical Research
### he/him/his @@@ Reuben P. Jacob, M.D. (he/him/his) – Department of Pathology and Laboratory Medicine, Children's Healthcare of Atlanta, Assistant Professor, Department of Pediatrics, Emory University School of Medicine ### 2038715###Program Chair###Medical Director Apheresis Service and Associate Director Transfusion Medicine/Blood Bank###Department of Pathology and Laboratory Medicine, Children's Healthcare of Atlanta, Assistant Professor, Department of Pediatrics, Emory University School of Medicine###
Program Chair: Reuben P. Jacob, M.D. (he/him/his) – Department of Pathology and Laboratory Medicine, Children's Healthcare of Atlanta, Assistant Professor, Department of Pediatrics, Emory University School of Medicine
### he/him/his AM24-MN-14-L
Oral Abstract - SPOTLIGHT Administrative - Assessing Blood Donor Risks (AM24-TU-07-L)
Favorite

Mary Townsend, MD (she/her/hers) – Vitalant ### 2118747###Program Chair###Vice President, Corporate Medical Director###Vitalant###
Program Chair: Mary Townsend, MD (she/her/hers) – Vitalant
### she/her/hers AM24-TU-07-L
Oral Abstract - SPOTLIGHT Extended Blood Storage (AM24-SN-23-L)
Favorite

Angelo D'Alessandro – University of Colorado Denver ### 833138###Program Chair######University of Colorado Denver###
Program Chair: Angelo D'Alessandro – University of Colorado Denver
### AM24-SN-23-L
Oral Abstract - Storage Lesion (AM24-ST-13-L)
Favorite

Cristina Figueroa Villalba, MD – Yale School of Medicine ### 2445448###Program Chair###Clinical Fellow###Yale School of Medicine###
Program Chair: Cristina Figueroa Villalba, MD – Yale School of Medicine
### @@@ John R. Hess, MD, MD, MPH, FACP, FAAAS – University of Washington School of Medicine ### 832985###Program Chair###Professor of Laboratory Medicine and Pathology, Medicine and Hematology###University of Washington School of Medicine###
Program Chair: John R. Hess, MD, MD, MPH, FACP, FAAAS – University of Washington School of Medicine
### AM24-ST-13-L
Oral Abstract - Transfusion Medicine Service Operations (AM24-MN-15-L)
Favorite

Elizabeth P. Crowe, MD, PhD – Johns Hopkins University School of Medicine ### 1765744###Program Chair###Asst. Professor and Medical Director of Blood Bank###Johns Hopkins University School of Medicine###
Program Chair: Elizabeth P. Crowe, MD, PhD – Johns Hopkins University School of Medicine
### @@@ Ingrid Perez-Alvarez, MD – Cedars-Sinai Medical Center ### 2118844###Program Chair######Cedars-Sinai Medical Center###
Program Chair: Ingrid Perez-Alvarez, MD – Cedars-Sinai Medical Center
### AM24-MN-15-L
Overview of Cell-Based Biologics Manufacturing as a Contracted Service (AM24-MN-26-L)
Favorite

Christie Malone, MT(ASCP)SBB, CABP – GenCure ### 2362118###Program Chair###Sr. Director, Custom Solutions and Sales Support###GenCure###
Program Chair: Christie Malone, MT(ASCP)SBB, CABP – GenCure
### @@@ Lee Buckler, JD (he/him/his) – Blood Centers of America ### 2038679###Speaker###SVP, Advanced Therapies###Blood Centers of America###
Speaker: Lee Buckler, JD (he/him/his) – Blood Centers of America
### he/him/his @@@ Rogelio Zamilpa, PhD – GenCure ### 2362150###Speaker###Senior Director of Manufacturing Science and Technology###GenCure###
Speaker: Rogelio Zamilpa, PhD – GenCure
### @@@ Sanjin Zvonic, PhD (he/him/his) – Dark Horse Consulting Group ### 2379990###Speaker###Sr. Vice President, Business Development###Dark Horse Consulting Group###
Speaker: Sanjin Zvonic, PhD (he/him/his) – Dark Horse Consulting Group
### he/him/his @@@ Dominic Clarke, PhD – Cryoport Systems ### 2380166###Speaker###Vice President of Technical Operations, IntegriCell###Cryoport Systems###
Speaker: Dominic Clarke, PhD – Cryoport Systems
### AM24-MN-26-L
P
Paradigm Changes in Transfusion Medicine – Disaster Preparedness (AM24-MN-21-L)

Favorite

Jose F. F. Quesada, MLS(ASCP), SBB – South Texas Blood & Tissue Center ### 2362146###Speaker###Sr. Director Manufacturing laboratory and IRL###South Texas Blood & Tissue Center###
Speaker: Jose F. F. Quesada, MLS(ASCP), SBB – South Texas Blood & Tissue Center
### @@@ Audra Taylor – South Texas Blood &Tissue ### 2362147###Speaker###Vice President for Blood Operations###South Texas Blood &Tissue###
Speaker: Audra Taylor – South Texas Blood &Tissue
### @@@ Samantha G. Ngamsuntikul, MD (she/her/hers) – BioBridge Global ### 1765588###Program Chair###Medical Director###BioBridge Global###
Program Chair: Samantha G. Ngamsuntikul, MD (she/her/hers) – BioBridge Global
### she/her/hers AM24-MN-21-L
Pediatric Transfusion Medicine: A Coming of Age Journey (presented by Cassandra Josephson, Emily Cooley Memorial Award recipient) (AM24-MN-25-L)
Favorite

Wen Lu, MD – Mayo Clinic ### 1762768###Program Chair###Transfusion Medicine Consultant, Medical Director Center for Regenerative Biotherapeutics###Mayo Clinic###
Program Chair: Wen Lu, MD – Mayo Clinic
### @@@ Naomi L.C Luban, MD (she/her/hers) – Children's National Hospital, GWU School of Medicine and Health Sciences ### 832725###Award Presenter###Vice Chair , Faculty Affairs, Professor of Pediatrics and Pathology ###Children's National Hospital, GWU School of Medicine and Health Sciences ###
Award Presenter: Naomi L.C Luban, MD (she/her/hers) – Children's National Hospital, GWU School of Medicine and Health Sciences
### she/her/hers @@@ Ravi M. Patel, MD, MSc (he/him/his) – Emory University and Children's Healthcare of Atlanta ### 836984###Award Presenter###Professor of Pediatrics###Emory University and Children's Healthcare of Atlanta###
Award Presenter: Ravi M. Patel, MD, MSc (he/him/his) – Emory University and Children's Healthcare of Atlanta
### he/him/his @@@ Cassandra Josephson, MD – Johns Hopkins University School of Medicine; Johns Hopkins All Children’s Hospital (JHACH) ### 2119021###Award Recipient ###Professor, Oncology, Pediatrics and Pathology; Hawkins Family Endowed Chair, Director, Cancer and Blood Disorders Institute; Director, Blood Bank, Transfusion, and Apheresis###Johns Hopkins University School of Medicine; Johns Hopkins All Children’s Hospital (JHACH)###
Award Recipient : Cassandra Josephson, MD – Johns Hopkins University School of Medicine; Johns Hopkins All Children’s Hospital (JHACH)
### AM24-MN-25-L
Phase IV Trial Of Pathogen-reduced Cryoprecipitate vs. Cryoprecipitated AHF to Lower Operative Transfusions (TOP-CLOT) in Cardiac Surgery (OA2-AM24-MN-23)
Favorite

Melissa M. Cushing, MD (she/her/hers) – Weill Cornell Medicine ### 2418139###Presenting Author###Clinical Laboratory Director###Weill Cornell Medicine###
Presenting Author: Melissa M. Cushing, MD (she/her/hers) – Weill Cornell Medicine
### she/her/hers OA2-AM24-MN-23
Physician Leadership Roundtable
Favorite

Claudia Cohn, MD, Phd – University of Minnesota ### 2362155###Speaker###Professor of Laboratory Medicine and Pathology, Dir. Blood Bank Lab., Ass. Dir. Clinical Lab.###University of Minnesota###
Speaker: Claudia Cohn, MD, Phd – University of Minnesota
### @@@ Leah Mendelsohn Stone, JD – Association for the Advancement of Blood and Biotherapies ### 2362154###Program Chair###Vice President, Public Policy and Advocacy###Association for the Advancement of Blood and Biotherapies###
Program Chair: Leah Mendelsohn Stone, JD – Association for the Advancement of Blood and Biotherapies
###
Plasma Transfusion Practice: A Multi-Center Audit of 10,008 Admissions with Plasma Transfusionat 23 Hospitals (OA3-AM24-MN-08)
Favorite

Nadia Gabarin, MD FRCPC (she/her/hers) – Canadian Blood Services ### 2119215###Presenting Author######Canadian Blood Services###
Presenting Author: Nadia Gabarin, MD FRCPC (she/her/hers) – Canadian Blood Services
### she/her/hers OA3-AM24-MN-08
Platelet Components With Persistent Aggregates Are More Activated, Which Does Not Change Following Pre-transfusion Filtration: The BEST Collaborative Study (OA3-AM24-ST-13)
Favorite

DENESE C. MARKS, PhD – Australian Red Cross Lifeblood ### 833084###Presenting Author###Research Program Leader- Product Development###Australian Red Cross Lifeblood###
Presenting Author: DENESE C. MARKS, PhD – Australian Red Cross Lifeblood
### OA3-AM24-ST-13
Plenary Oral Abstract Session (AM24-SN-27-L)

Favorite

Melissa M. Cushing, MD (she/her/hers) – Weill Cornell Medicine ### 2418139###Program Chair###Clinical Laboratory Director###Weill Cornell Medicine###
Program Chair: Melissa M. Cushing, MD (she/her/hers) – Weill Cornell Medicine
### she/her/hers AM24-SN-27-L
Point-of-care Transfusion Services With Remote, "Smart" Refrigerators Can Alleviate Laboratory Staffing Emergencies (AM24-SN-10-L)
Favorite

Melissa M. Cushing, MD (she/her/hers) – Weill Cornell Medicine ### 2418139###Program Chair###Clinical Laboratory Director###Weill Cornell Medicine###
Program Chair: Melissa M. Cushing, MD (she/her/hers) – Weill Cornell Medicine
### she/her/hers @@@ Robert A. DeSimone, MD – New York-Presbyterian Hospital/Weill Cornell Medicine ### 833410###Speaker###Director of Transfusion Medicine###New York-Presbyterian Hospital/Weill Cornell Medicine###
Speaker: Robert A. DeSimone, MD – New York-Presbyterian Hospital/Weill Cornell Medicine
### @@@ Stephanie Kinney, MD (she/her/hers) – Cincinnati Children’s Hospital Medical Center ### 833430###Speaker###Medical Director of Clinical Laboratories###Cincinnati Children’s Hospital Medical Center###
Speaker: Stephanie Kinney, MD (she/her/hers) – Cincinnati Children’s Hospital Medical Center
### she/her/hers AM24-SN-10-L
Predictors of Off-site Loss of Consciousness or Major Injury Across the Donor Age Spectrum (OA3-AM24-SN-15)
Favorite

Ralph R. Vassallo, MD FACP – Vitalant ### 2419098###Presenting Author###EVP / Chief Medical & Scientific Officer###Vitalant###
Presenting Author: Ralph R. Vassallo, MD FACP – Vitalant
### OA3-AM24-SN-15
Preparing for the Data Deluge: Mitigating the Informatics Challenges of Expanded RBC Genotyping Data (AM24-ST-07-L)
Favorite

John C. Spinosa, MD, PhD – Lantana Consulting Group ### 2362178###Speaker###Chief Medical Advisor###Lantana Consulting Group###
Speaker: John C. Spinosa, MD, PhD – Lantana Consulting Group
### @@@ Ross Fasano, MD – Emory University ### 2038667###Program Chair###Associate Professor of Pathology and Pediatric Hematology/Oncology###Emory University###
Program Chair: Ross Fasano, MD – Emory University
### @@@ Marianne E.M Yee, MD, MSCR (she/her/hers) – Emory University and Children's Healthcare of Atlanta ### 2118207###Speaker###Associate Professor of Pediatrics, Hematology###Emory University and Children's Healthcare of Atlanta###
Speaker: Marianne E.M Yee, MD, MSCR (she/her/hers) – Emory University and Children's Healthcare of Atlanta
### she/her/hers AM24-ST-07-L
Prevalence of Anti-HBs In Anti-HBc Only Reactive Blood Donors – Implications For A Strategy To Mitigate Donor Deferral And Donation Discard (OA4-AM24-ST-27)
Favorite

Guillermo Orjuela, MD, MS (he/him/his) – Abbott ### 2418300###Presenting Author###Medical Director LATAM###Abbott###
Presenting Author: Guillermo Orjuela, MD, MS (he/him/his) – Abbott
### he/him/his OA4-AM24-ST-27
Preventing Blood Product Tracking In a Mass Casualty Event from Becoming a Disaster (AM24-MN-12-L)
Favorite

Ricardo Sumugod, MS, MLS(ASCP)SBB (he/him/his) – Northwestern Medicine ### 2362126###Speaker###Director, Clinical Laboratories###Northwestern Medicine###
Speaker: Ricardo Sumugod, MS, MLS(ASCP)SBB (he/him/his) – Northwestern Medicine
### he/him/his @@@ Crystal Theiler, MLS(ASCP)SBB CM – Aurora Medical Center/ Advocate Health ### 2362127###Speaker###Transfusion Service Regional Coordinator###Aurora Medical Center/ Advocate Health###
Speaker: Crystal Theiler, MLS(ASCP)SBB CM – Aurora Medical Center/ Advocate Health
### @@@ Colleen A. Aronson, BS, MT(ASCP)SBB (she/her/hers) – Advocate Health ### 2118454###Program Chair###Technical Director Midwest Region###Advocate Health###
Program Chair: Colleen A. Aronson, BS, MT(ASCP)SBB (she/her/hers) – Advocate Health
### she/her/hers AM24-MN-12-L
Prolonged Storage of Leukoreduced Whole Blood Stored in CPD from 21 to 35 Days to Improve Prehospital Blood Supply Logistics (OA4-AM24-SN-23)
Favorite

Hanne Braathen, MSc (she/her/hers) – Haukeland University Hospital ### 2418110###Presenting Author###Biomedical Laboratory Scientist###Haukeland University Hospital###
Presenting Author: Hanne Braathen, MSc (she/her/hers) – Haukeland University Hospital
### she/her/hers OA4-AM24-SN-23
R
Radio Frequency Identification (RFID) Technology Impact on the Tracking RBC Units in the Emergency Department Refrigerator and on the Blood Bank Inventory (OA2-AM24-MN-15)
Favorite

Lejla Music Aplenc, MD – Children's Mercy ### 2119159###Presenting Author######Children's Mercy###
Presenting Author: Lejla Music Aplenc, MD – Children's Mercy
### OA2-AM24-MN-15
Randomized Controlled Trial of Pathogen Reduced Platelets Compared to Non-Pathogen Reduced Platelets for Correction of Viscoelastic Platelet Function Testing in Cardiac Surgery (OA3-AM24-MN-23)
Favorite

Magali J. Fontaine, MD, PhD (she/her/hers) – University of Maryland School of Medicine ### 2119655###Presenting Author###Professor of Pathology and Medicine and Medical Director###University of Maryland School of Medicine###
Presenting Author: Magali J. Fontaine, MD, PhD (she/her/hers) – University of Maryland School of Medicine
### she/her/hers OA3-AM24-MN-23
Rapid Association and Dissociation of a Monoclonal anti-Duffy Antibody to Duffy Expressing Red Blood Cells in a Mouse Model (OA3-AM24-TU-14)
Favorite

Ryan P. Jajosky, MD – Brigham and Women's Hospital ### 1762776###Presenting Author######Brigham and Women's Hospital###
Presenting Author: Ryan P. Jajosky, MD – Brigham and Women's Hospital
### OA3-AM24-TU-14
Rapid Isolation of CD4+ T Cells Using a Functionally Closed Microfluidic System for Generating Induced Regulatory T Cells for Adoptive Therapy (OA4-AM24-TU-06)
Favorite

Sergey S. Shevkoplyas, PhD – University of Houston ### 2418247###Presenting Author###Professor of Biomedical Engineering###University of Houston###
Presenting Author: Sergey S. Shevkoplyas, PhD – University of Houston
### OA4-AM24-TU-06
RBC Transfusions for Patients with Hematologic Conditions: Hemoglobin Thresholds, Iron Metabolism (AM24-ST-05-L)
Favorite

Monica B. Pagano, MD (she/her/hers) – University of Washington ### 832984###Speaker###Division Head of Transfusion Medicine###University of Washington###
Speaker: Monica B. Pagano, MD (she/her/hers) – University of Washington
### she/her/hers @@@ Kleber Y. Fertrin, MD, PhD (he/him/his) – Fred Hutch Cancer Center ### 2362128###Speaker###Director, Sickle Cell Disease and Iron Overload Program, Fred Hutchinson Cancer Center###Fred Hutch Cancer Center###
Speaker: Kleber Y. Fertrin, MD, PhD (he/him/his) – Fred Hutch Cancer Center
### he/him/his @@@ Katerina Pavenski, MD (she/her/hers) – Associate Professor, Departments of Medicine and Laboratory Medicine & Pathobiology, University of Toronto ### 2038661###Program Chair###Head, Division Transfusion Medicine, Department of Laboratory Medicine, St. Michael’s Hospital###Associate Professor, Departments of Medicine and Laboratory Medicine & Pathobiology, University of Toronto###
Program Chair: Katerina Pavenski, MD (she/her/hers) – Associate Professor, Departments of Medicine and Laboratory Medicine & Pathobiology, University of Toronto
### she/her/hers AM24-ST-05-L
Real-World Feasibility of a Universal Blood Donor Typing Array for Large-Scale Genotyping of Red Cell, Platelet, and Leukocyte Antigens in an International Multi-Ethnic Donor Cohort (OA3-AM24-TU-15)
Favorite

William J. Lane, MD, PhD, A(ACHI) – Brigham and Women's Hosptial ### 2118974###Presenting Author###Tissue Typing Lab Director###Brigham and Women's Hosptial###
Presenting Author: William J. Lane, MD, PhD, A(ACHI) – Brigham and Women's Hosptial
### OA3-AM24-TU-15
Rebuilding Trust: Canadian Blood Services Issues Historic Apology to 2SLGBTQIA+ Communities (OA3-AM24-TU-07)
Favorite

Graham Sher, O.C (he/him/his) – Canadian Blood Services ### 2042504###Presenting Author###CEO###Canadian Blood Services###
Presenting Author: Graham Sher, O.C (he/him/his) – Canadian Blood Services
### he/him/his OA3-AM24-TU-07
Red Blood Cell (RBC) Alloimmunization after Intrauterine Transfusion (OA4-AM24-MN-07)
Favorite

Gisela Marrero-Rivera, MD (she/her/hers) – University of California San Francisco ### 2118886###Presenting Author###Assistant Clinical Professor###University of California San Francisco###
Presenting Author: Gisela Marrero-Rivera, MD (she/her/hers) – University of California San Francisco
### she/her/hers OA4-AM24-MN-07
Red Blood Cell Transfusion During 814,564 Admissions to 24 hospitals: Wide Variability in Transfusion Practice Across Hospitals, Physicians, and Patient Diagnoses (OA4-AM24-MN-08)
Favorite

Sheharyar Raza, MD, FRCPC (he/him/his) – Canadian Blood Services ### 2418337###Presenting Author######Canadian Blood Services###
Presenting Author: Sheharyar Raza, MD, FRCPC (he/him/his) – Canadian Blood Services
### he/him/his OA4-AM24-MN-08
Research and Progress Session (RAPS) - Apheresis and Stem Cell Processing for Novel Biotherapies
Favorite

Suzanne Thibodeaux, MD, PhD, CABP(H) (she/her/hers) – Washington University School of Medicine ### 833164###Program Chair###Associate Professor###Washington University School of Medicine###
Program Chair: Suzanne Thibodeaux, MD, PhD, CABP(H) (she/her/hers) – Washington University School of Medicine
### she/her/hers @@@ Tracey Hlucky – Kite Pharma, a Gilead Co ### 1782409###Speaker###Senior Manager, QA###Kite Pharma, a Gilead Co###
Speaker: Tracey Hlucky – Kite Pharma, a Gilead Co
### @@@ Kevin J. Land, MD – Vitalant ### 837509###Speaker###VP Clinical Services###Vitalant###
Speaker: Kevin J. Land, MD – Vitalant
### @@@ Scott Avecilla – Weill Cornell Medicine ### 833003###Speaker######Weill Cornell Medicine###
Speaker: Scott Avecilla – Weill Cornell Medicine
### @@@ Kyle Annen, DO, CABP, QIA (ASCP) (she/her/hers) – Department of Pathology, University of Colorado-Anschutz School of Medicine ### 1765782###Speaker###Medical Director of Apheresis and Cellular Therapy###Department of Pathology, University of Colorado-Anschutz School of Medicine###
Speaker: Kyle Annen, DO, CABP, QIA (ASCP) (she/her/hers) – Department of Pathology, University of Colorado-Anschutz School of Medicine
### she/her/hers @@@ Thomas Z. Thompson, M.D., CABP – Mayo Clinic ### 2418718###Speaker######Mayo Clinic###
Speaker: Thomas Z. Thompson, M.D., CABP – Mayo Clinic
### @@@ Monica Avila, MT (ASCP) – CMC Alliance &Project Management at Cellenkos Inc ### 2504546###Speaker###Sr. Director###CMC Alliance &Project Management at Cellenkos Inc###
Speaker: Monica Avila, MT (ASCP) – CMC Alliance &Project Management at Cellenkos Inc
###
Residual Red Blood Cells (rRBC) and Microparticles (MP) in Apheresis Platelet Products (OA4-AM24-ST-13)
Favorite

Susanne Marschner (she/her/hers) – Vitalant Research Institute ### 832445###Presenting Author###VP Research & Scientific Programs###Vitalant Research Institute###
Presenting Author: Susanne Marschner (she/her/hers) – Vitalant Research Institute
### she/her/hers OA4-AM24-ST-13
Resilience Explored: Navigating Post-Pandemic Blood Products Utilization Trends and Supply Challenges in North America (AM24-MN-33-L)
Favorite

Ruchika Goel, MD, MPH, CABP (she/her/hers) – Vitalant and Johns Hopkins University ### 2362125###Program Chair###Senior Medical Director, Corporate Medical Affairs. Professor of Internal Medicine and Pediatrics###Vitalant and Johns Hopkins University###
Program Chair: Ruchika Goel, MD, MPH, CABP (she/her/hers) – Vitalant and Johns Hopkins University
### she/her/hers @@@ Courtney Hopkins, DO (she/her/hers) – Vitalant ### 2038693###Speaker###Senior Medical Officer###Vitalant###
Speaker: Courtney Hopkins, DO (she/her/hers) – Vitalant
### she/her/hers @@@ Baia J. Lasky, MD – American Red Cross ### 1765630###Speaker###Divisional Chief Medical Director###American Red Cross###
Speaker: Baia J. Lasky, MD – American Red Cross
### @@@ Asim Alam, FRCPC, DRCPSC (he/him/his) – Canadian Blood Services, University of Toronto ### 2433812###Speaker###Medical Director, Assistant Professor###Canadian Blood Services, University of Toronto###
Speaker: Asim Alam, FRCPC, DRCPSC (he/him/his) – Canadian Blood Services, University of Toronto
### he/him/his AM24-MN-33-L
S
SBB/BB Exam Review 2024 (AM24-SN-04-L)
Favorite

Jayanna K. Slayten, MS MLS(ASCP) SBBCM (she/her/hers) – Indiana University Health ### 1762668###Program Chair###Coordinator of Quality and Analytics###Indiana University Health###
Program Chair: Jayanna K. Slayten, MS MLS(ASCP) SBBCM (she/her/hers) – Indiana University Health
### she/her/hers @@@ Kaitlyn Taylor, SBB(ASCP) – LifeShare Blood Center ### 2118710###Speaker###Medical Technologist II###LifeShare Blood Center###
Speaker: Kaitlyn Taylor, SBB(ASCP) – LifeShare Blood Center
### @@@ Michelle Lodermeier, MBA, MLS(ASCP)SBB (she/her/hers) – American Red Cross ### 1762671###Speaker###Sr. Program Manager, BBT###American Red Cross###
Speaker: Michelle Lodermeier, MBA, MLS(ASCP)SBB (she/her/hers) – American Red Cross
### she/her/hers @@@ Natasha M. Leon, MLS(ASCP)SBBCM – Versiti ### 1762670###Speaker###Clinical Education Specialist###Versiti###
Speaker: Natasha M. Leon, MLS(ASCP)SBBCM – Versiti
### @@@ Wyenona Hicks, MS, MT(ASCP)SBB (she/her/hers) – Self ### 1762669###Speaker###Educator/Author###Self###
Speaker: Wyenona Hicks, MS, MT(ASCP)SBB (she/her/hers) – Self
### she/her/hers @@@ Diana L. Riddle, MSTM, MLS(ASCP)cmSBBcm – University of Texas Medical Branch ### 1762672###Speaker###Assistant Professor###University of Texas Medical Branch###
Speaker: Diana L. Riddle, MSTM, MLS(ASCP)cmSBBcm – University of Texas Medical Branch
### @@@ Sarah Burnett-Greenup, MS, MLS(ASCP)CMSBBCM – The University of Texas Medical Branch, Galveston ### 2087180###Speaker###Assistant Professor of Instruction###The University of Texas Medical Branch, Galveston###
Speaker: Sarah Burnett-Greenup, MS, MLS(ASCP)CMSBBCM – The University of Texas Medical Branch, Galveston
### @@@ Paul Mansfield, MLS(ASCP)SBB – American Red Cross ### 833235###Speaker###Director, IRL###American Red Cross###
Speaker: Paul Mansfield, MLS(ASCP)SBB – American Red Cross
### @@@ Kathy Haddaway, MLS(ASCP)CMSBBCM – Johns Hopkins Hospital ### 1762673###Speaker###Technical Specialist II###Johns Hopkins Hospital###
Speaker: Kathy Haddaway, MLS(ASCP)CMSBBCM – Johns Hopkins Hospital
### @@@ Traci Paige, MT(ASCP)SBBcm (she/her/hers) – The National Institutes of Health ### 837512###Speaker###Supervisory Clinical Laboratory Scientist###The National Institutes of Health###
Speaker: Traci Paige, MT(ASCP)SBBcm (she/her/hers) – The National Institutes of Health
### she/her/hers AM24-SN-04-L
Should Rh Immune Globulin Be Administered After First Trimester Bleeding Events? (AM24-MN-10-L)

Favorite

Julie K. Karp, MD (she/her/hers) – Thomas Jefferson University Hospital ### 833151###Program Chair###Medical Director, Transfusion Medicine###Thomas Jefferson University Hospital###
Program Chair: Julie K. Karp, MD (she/her/hers) – Thomas Jefferson University Hospital
### she/her/hers @@@ Sarah Horvath, MD, MSHP, FACOG (she/her/hers) – Penn State Hershey Medical Center ### 2362115###Speaker###Associate Professor of Obstetrics and Gynecology###Penn State Hershey Medical Center###
Speaker: Sarah Horvath, MD, MSHP, FACOG (she/her/hers) – Penn State Hershey Medical Center
### she/her/hers AM24-MN-10-L
Sickle Cell Disease: Inching towards Transfusion Independence. Exploring the Journey from Chronic Transfusions to the Novel Biotherapeutics (AM24-SN-17-L)

Favorite

Ross Fasano, MD – Emory University ### 2038667###Speaker###Associate Professor of Pathology and Pediatric Hematology/Oncology###Emory University###
Speaker: Ross Fasano, MD – Emory University
### @@@ Jeanne E. Hendrickson, MD – Emory University ### 2038689###Program Chair###Professor, Department of Pathology and Laboratory Medicine Emory University School of Medicine###Emory University###
Program Chair: Jeanne E. Hendrickson, MD – Emory University
### @@@ Ruchika Goel, MD, MPH, CABP (she/her/hers) – Vitalant and Johns Hopkins University ### 2362125###Speaker###Senior Medical Director, Corporate Medical Affairs. Professor of Internal Medicine and Pediatrics###Vitalant and Johns Hopkins University###
Speaker: Ruchika Goel, MD, MPH, CABP (she/her/hers) – Vitalant and Johns Hopkins University
### she/her/hers AM24-SN-17-L
Sickle Cell Disease Psychosocial Support and Advocacy (AM24-ST-15-L)
Favorite

Yvette C. Tanhehco, MD, PhD, MS, CABP(AABB) – Department of Pathology and Cell Biology, Columbia University Irving Medical Center ### 1762769###Program Chair###Associate Professor of Pathology and Cell Biology, Medical Director of Cellular Therapy Laboratory###Department of Pathology and Cell Biology, Columbia University Irving Medical Center###
Program Chair: Yvette C. Tanhehco, MD, PhD, MS, CABP(AABB) – Department of Pathology and Cell Biology, Columbia University Irving Medical Center
### @@@ Yvette C. Tanhehco, MD, PhD, MS, CABP(AABB) – Department of Pathology and Cell Biology, Columbia University Irving Medical Center ### 1762769###Speaker###Associate Professor of Pathology and Cell Biology, Medical Director of Cellular Therapy Laboratory###Department of Pathology and Cell Biology, Columbia University Irving Medical Center###
Speaker: Yvette C. Tanhehco, MD, PhD, MS, CABP(AABB) – Department of Pathology and Cell Biology, Columbia University Irving Medical Center
### @@@ Adrienne Shapiro (she/her/hers) – Axis Advocacy ### 2362117###Speaker###Founder & CEO###Axis Advocacy###
Speaker: Adrienne Shapiro (she/her/hers) – Axis Advocacy
### she/her/hers AM24-ST-15-L
Solve It! Scenarios in Apheresis and Cellular Therapy (AM24-MN-30-L)
Favorite

Vasiliki E. Kalodimou, Professor Dr. CABP (H), IARMES (she/her/hers) – IASO Materbity & Research Hospital & EUC ### 1782973###Program Chair###Director Flow Cytometry-Research & Regenerative Medicine & Professor of Regenerative Medicine and Cellular Therapies###IASO Materbity & Research Hospital & EUC###
Program Chair: Vasiliki E. Kalodimou, Professor Dr. CABP (H), IARMES (she/her/hers) – IASO Materbity & Research Hospital & EUC
### she/her/hers AM24-MN-30-L
Source Plasma for Further Manufacture and Transfusion Medicine – Finding Common Ground (AM24-MN-01-L)
Favorite

Toby Simon, MD (he/him/his) – Self employed ### 2362133###Speaker###Senior Medical Consultant###Self employed###
Speaker: Toby Simon, MD (he/him/his) – Self employed
### he/him/his @@@ James Knowles, PhD (he/him/his) – Plasma Protein Therapeutics Association ### 2362141###Speaker###Senior Director, Head Global Regulatory Policy###Plasma Protein Therapeutics Association###
Speaker: James Knowles, PhD (he/him/his) – Plasma Protein Therapeutics Association
### he/him/his @@@ Michelle Fransen, MPH, MPS (she/her/hers) – Plasma Protein Therapeutics Association ### 2362132###Program Chair###Director, Lead for Study Management###Plasma Protein Therapeutics Association###
Program Chair: Michelle Fransen, MPH, MPS (she/her/hers) – Plasma Protein Therapeutics Association
### she/her/hers AM24-MN-01-L
Sterility Testing for Cellular Therapies: Updates and Challenges. What should we be doing? (AM24-ST-09-L)
Favorite

J. Wade Atkins, MS, MLS, SBB, CQA, CABP(H) – NIH/CC/DTM ### 2362113###Program Chair###Supervisor, QA and RA###NIH/CC/DTM###
Program Chair: J. Wade Atkins, MS, MLS, SBB, CQA, CABP(H) – NIH/CC/DTM
### @@@ Dr. Anna Lau, PhD, D(ABMM) (she/her/hers) – NIH/CC/DLM ### 2362114###Speaker###Chief, Sterility Testing Service###NIH/CC/DLM###
Speaker: Dr. Anna Lau, PhD, D(ABMM) (she/her/hers) – NIH/CC/DLM
### she/her/hers @@@ Elizabeth Lessey-Morillon, PhD, RAC (she/her/hers) – Center for Biologics Evaluation and Research; Office of Therapeutic Products; Office of Cellular Therapy & Human Tissue CMC; U.S. Food and Drug Administration ### 2482960###Speaker###Senior Biologist###Center for Biologics Evaluation and Research; Office of Therapeutic Products; Office of Cellular Therapy & Human Tissue CMC; U.S. Food and Drug Administration###
Speaker: Elizabeth Lessey-Morillon, PhD, RAC (she/her/hers) – Center for Biologics Evaluation and Research; Office of Therapeutic Products; Office of Cellular Therapy & Human Tissue CMC; U.S. Food and Drug Administration
### she/her/hers AM24-ST-09-L
T
Targeted Quantitative NGS Uncovers 5 RH Alleles in Two Unrelated Patients, With DAU6 and Pseudogene in a Possible Tandem Arrangement (OA4-AM24-TU-15)
Favorite

Sunitha Vege, MS – New York Blood Center ### 832987###Presenting Author###Sr Technical Director, Genomics###New York Blood Center###
Presenting Author: Sunitha Vege, MS – New York Blood Center
### OA4-AM24-TU-15
The AABB Cellular Starting Material Forum: From Consent to Characterization - Enhancing Allogeneic Donor Practices (AM24-MN-41-L)
Favorite

Jeff Wren – AABB ### 2411791###Program Chair###Vice President of Biotherapies###AABB###
Program Chair: Jeff Wren – AABB
### @@@ Priya Baraniak, PhD (she/her/hers) – OrganaBio ### 2438381###Speaker###Chief Business Officer###OrganaBio###
Speaker: Priya Baraniak, PhD (she/her/hers) – OrganaBio
### she/her/hers @@@ Colleen Delaney, MD, MSc (she/her/hers) – Deverra Therapeutics ### 2438382###Speaker###Founder and Chief Scientific Officer###Deverra Therapeutics###
Speaker: Colleen Delaney, MD, MSc (she/her/hers) – Deverra Therapeutics
### she/her/hers @@@ Diana Hernandez, BSc PhD (she/her/hers) – Anthony Nolan Research Institute ### 2438383###Speaker###Director of Immune and Advanced Therapies###Anthony Nolan Research Institute###
Speaker: Diana Hernandez, BSc PhD (she/her/hers) – Anthony Nolan Research Institute
### she/her/hers @@@ Heather P. Munoz, MN, RN, CPN, CPHON, QIA (she/her/hers) – Sana Biotechnology ### 2438384###Speaker###Director###Sana Biotechnology###
Speaker: Heather P. Munoz, MN, RN, CPN, CPHON, QIA (she/her/hers) – Sana Biotechnology
### she/her/hers @@@ Robert Tressler, MS, PhD – Excellos ### 2143819###Speaker###Chief Scientific Officer###Excellos###
Speaker: Robert Tressler, MS, PhD – Excellos
### AM24-MN-41-L
The Changing Landscape of Managing a Rare Blood Frozen Inventory (AM24-SN-08-L)
Favorite

Sandy Wortman, MLS (ASCP) SBB – Carter Bloodcare ### 2118011###Speaker###Director- Reference and Transfusion Laboratory Services###Carter Bloodcare###
Speaker: Sandy Wortman, MLS (ASCP) SBB – Carter Bloodcare
### @@@ Margaret A. Keller, PhD (she/her/hers) – American Red Cross ### 832938###Speaker###Executive, National Laboratories Senior Director, American Rare Donor Program American Red Cross###American Red Cross###
Speaker: Margaret A. Keller, PhD (she/her/hers) – American Red Cross
### she/her/hers @@@ Claribel Resto, MLS(ASCP) SBB – OneBlood ### 2362189###Program Chair###Director, Immunohematology Reference Laboratories###OneBlood###
Program Chair: Claribel Resto, MLS(ASCP) SBB – OneBlood
### AM24-SN-08-L
The Effect of Age and Gender on Anti-A/B IgM Antibody Titers in O Rh(D) Positive Donors (OA2-AM24-SN12)
Favorite

Samantha G. Ngamsuntikul, MD (she/her/hers) – BioBridge Global ### 1765588###Presenting Author###Medical Director###BioBridge Global###
Presenting Author: Samantha G. Ngamsuntikul, MD (she/her/hers) – BioBridge Global
### she/her/hers OA2-AM24-SN12
The Efficacy And Safety Of Whole Blood Exchange Transfusion In Sepsis With Anemia (OA3-AM24-MN-39)
Favorite

Ning Li, MA PhD MD Professor (he/him/his) – Department of Blood Transfusion, Clinical Transfusion Research Center, Xiangya Hospital, Central South University ### 2418224###Presenting Author###Director###Department of Blood Transfusion, Clinical Transfusion Research Center, Xiangya Hospital, Central South University###
Presenting Author: Ning Li, MA PhD MD Professor (he/him/his) – Department of Blood Transfusion, Clinical Transfusion Research Center, Xiangya Hospital, Central South University
### he/him/his OA3-AM24-MN-39
The Future of Cellular Therapy Using Mesenchymal Stromal Cells and Dendritic Cells (AM24-SN-01-L)
Favorite

Wen Lu, MD – Mayo Clinic ### 1762768###Program Chair###Transfusion Medicine Consultant, Medical Director Center for Regenerative Biotherapeutics###Mayo Clinic###
Program Chair: Wen Lu, MD – Mayo Clinic
### @@@ Jacques Galipeau, MD – University of Wisconsin in Madison ### 2362110###Speaker###Associate Dean for Therapeutics Development###University of Wisconsin in Madison###
Speaker: Jacques Galipeau, MD – University of Wisconsin in Madison
### @@@ Michael P. Gustafson, PhD – Mayo Clinic in Arizona ### 2362111###Speaker###Consultant, Laboratory Medicine and Pathology###Mayo Clinic in Arizona###
Speaker: Michael P. Gustafson, PhD – Mayo Clinic in Arizona
### AM24-SN-01-L
The Importance of Mentors...or The Long and Winding Road (presented by LeeAnn Walker, Sally Frank Memorial Award recipient) (AM24-ST-03-L)
Favorite

Paul Mansfield, MLS(ASCP)SBB – American Red Cross ### 833235###Program Chair###Director, IRL###American Red Cross###
Program Chair: Paul Mansfield, MLS(ASCP)SBB – American Red Cross
### @@@ Jayanna K. Slayten, MS MLS(ASCP) SBBCM (she/her/hers) – Indiana University Health ### 1762668###Award Presenter###Coordinator of Quality and Analytics###Indiana University Health###
Award Presenter: Jayanna K. Slayten, MS MLS(ASCP) SBBCM (she/her/hers) – Indiana University Health
### she/her/hers @@@ LeeAnn Walker, MEd, MLS(ASCP)SBB – The University of Texas Medical Branch, Galveston ### 2118013###Award Recipient ###Adjunct Associate Professor###The University of Texas Medical Branch, Galveston###
Award Recipient : LeeAnn Walker, MEd, MLS(ASCP)SBB – The University of Texas Medical Branch, Galveston
### AM24-ST-03-L
The Relationship Between Rurality and Transfusion-Transmissible Infections Among Blood Donors and the Influence of Demographic Characteristics (OA4-AM24-TU-07)
Favorite

Galen Conti, MPH – American Red Cross ### 2119448###Presenting Author###Lead Epidemiologist###American Red Cross###
Presenting Author: Galen Conti, MPH – American Red Cross
### OA4-AM24-TU-07
The Role of Blood Operators and Transfusion Services in Preventing and Responding to Transfusion-transmitted Malaria (AM24-MN-35-L)
Favorite

Steven Drews, PhD FCCM D(ABMM) (he/him/his) – Donation Policy and Studies, Canadian Blood Services; Professor, Division of Diagnostic and Applied Microbiology, University of Alberta, Edmonton, AB, Canada. ### 832522###Program Chair###Associate Director, Microbiology, Canadian Blood Services###Donation Policy and Studies, Canadian Blood Services; Professor, Division of Diagnostic and Applied Microbiology, University of Alberta, Edmonton, AB, Canada.###
Program Chair: Steven Drews, PhD FCCM D(ABMM) (he/him/his) – Donation Policy and Studies, Canadian Blood Services; Professor, Division of Diagnostic and Applied Microbiology, University of Alberta, Edmonton, AB, Canada.
### he/him/his @@@ Susan Nahirniak, MD, FRCPC (she/her/hers) – Transfusion and Transplantation Medicine, Alberta Precision Laboratories & Laboratory Medicine & Pathology, University of Alberta ### 1765751###Speaker###Medical Director & Professor###Transfusion and Transplantation Medicine, Alberta Precision Laboratories & Laboratory Medicine & Pathology, University of Alberta###
Speaker: Susan Nahirniak, MD, FRCPC (she/her/hers) – Transfusion and Transplantation Medicine, Alberta Precision Laboratories & Laboratory Medicine & Pathology, University of Alberta
### she/her/hers @@@ Rita A. Reik, MD FCAP (she/her/hers) – OneBlood ### 833010###Speaker###Chief Medical Officer###OneBlood###
Speaker: Rita A. Reik, MD FCAP (she/her/hers) – OneBlood
### she/her/hers AM24-MN-35-L
The Use of HLA-Typed Cellular Transfusions and/or Infusions for In Vivo Adsorption of Donor-Specific HLA Antibodies (DSAs) as a Desensitization Strategy for Hematopoietic Stem Cell Transplant Patients (AM24-ST-01-L)
Favorite

Deanna C. Fang, MD – UC San Diego School of Medicine ### 2038714###Speaker###Associate Director of Immunogenetics & Transplantation Laboratory###UC San Diego School of Medicine###
Speaker: Deanna C. Fang, MD – UC San Diego School of Medicine
### @@@ Stefan Ciurea, MD – UNIVERSITY OF CALIFORNIA, IRVINE ### 2362170###Speaker###Director, Hematopoietic Stem Cell Transplant and Cellular Therapy Program###UNIVERSITY OF CALIFORNIA, IRVINE###
Speaker: Stefan Ciurea, MD – UNIVERSITY OF CALIFORNIA, IRVINE
### @@@ Minh-Ha Tran, DO – AABB Member ### 2362121###Program Chair###Medical Director###AABB Member###
Program Chair: Minh-Ha Tran, DO – AABB Member
### AM24-ST-01-L
There’s a Blood Donation Bill Proposed to Require WHAT!?—Navigating the Legislative Proposal and Change Process (AM24-MN-04-L)
Favorite

Susan M. Wilson, BS, MLS(ASCP)SBB – . ### 837556###Program Chair###.###.###
Program Chair: Susan M. Wilson, BS, MLS(ASCP)SBB – .
### @@@ Susan W. Noone, MPH, CQA(ASQ) (she/her/hers) – Vitalant, Central Coast ### 1762687###Speaker###Regional Director###Vitalant, Central Coast###
Speaker: Susan W. Noone, MPH, CQA(ASQ) (she/her/hers) – Vitalant, Central Coast
### she/her/hers @@@ Susan N. Leppke, MPH (she/her/hers) – AABB ### 1762770###Speaker###Senior Director, Public Policy & Strategic Partnerships###AABB###
Speaker: Susan N. Leppke, MPH (she/her/hers) – AABB
### she/her/hers AM24-MN-04-L
THOR-AABB Collaborative Session: Hemostatic Resuscitation Practice for Women, Prehospital Programs, and International Implementation (AM24-ST-04-L)
Favorite

Alyssa Ziman, MD – Department of Pathology and Laboratory Medicine, David Geffen School of Medicine at UCLA ### 833810###Speaker###Section Chief, Transfusion Medicine; CLIA Medical Director, Clinical Laboratories, Ronald Reagan UCLA Medical Center ###Department of Pathology and Laboratory Medicine, David Geffen School of Medicine at UCLA###
Speaker: Alyssa Ziman, MD – Department of Pathology and Laboratory Medicine, David Geffen School of Medicine at UCLA
### @@@ Phil Spinella, MD – University of Pittsburgh ### 2042499###Speaker###Co-Director, Trauma and Transfusion Medicine Center###University of Pittsburgh###
Speaker: Phil Spinella, MD – University of Pittsburgh
### @@@ Molly Sherwood – Allo Hope Foundation ### 2042500###Speaker###Director of Research###Allo Hope Foundation###
Speaker: Molly Sherwood – Allo Hope Foundation
### @@@ Bryan A. Cotton, MD, MPH, FACS – Memorial Hermann Hospital ### 2406572###Speaker###Professor of Surgery, McGovern Medical School Director of Trauma Surgery & Surgical Critical Care Fellowships###Memorial Hermann Hospital###
Speaker: Bryan A. Cotton, MD, MPH, FACS – Memorial Hermann Hospital
### @@@ Mark Yazer, MD – University of Pittsburgh ### 837474###Program Chair###Professor of Pathology###University of Pittsburgh###
Program Chair: Mark Yazer, MD – University of Pittsburgh
### @@@ John B. Holcomb, MD – University of Alabama at Birmingham ### 2042498###Speaker###Professor of Surgery###University of Alabama at Birmingham###
Speaker: John B. Holcomb, MD – University of Alabama at Birmingham
### @@@ Audra Taylor – South Texas Blood &Tissue ### 2362147###Speaker###Vice President for Blood Operations###South Texas Blood &Tissue###
Speaker: Audra Taylor – South Texas Blood &Tissue
### @@@ Joanne Pink, MD, FRCPA, FRACP – Australian Red Cross Lifeblood ### 1765585###Speaker###Chief Medical Officer###Australian Red Cross Lifeblood###
Speaker: Joanne Pink, MD, FRCPA, FRACP – Australian Red Cross Lifeblood
### @@@ Vanessa Agostini – IRCCS Ospedale Policlinico San Martino Genova ### 2406573###Speaker###Director of transfusion medicine department; director of regional blood center-Liguria Italy###IRCCS Ospedale Policlinico San Martino Genova ###
Speaker: Vanessa Agostini – IRCCS Ospedale Policlinico San Martino Genova
### @@@ Daise Esswein Muller, MD – SAMU Aeromédico de Santa Catarina, Brasil ### 2406574###Speaker###Medical chief###SAMU Aeromédico de Santa Catarina, Brasil###
Speaker: Daise Esswein Muller, MD – SAMU Aeromédico de Santa Catarina, Brasil
### AM24-ST-04-L
Trans, Non-binary, and Gender-Diverse Peoples: How You Can Make a Difference for Donors, Patients, and Communities (AM24-MN-43-L)
Favorite

Phil Accooe, MBA, MS, MLS(ASCP)SBB, CLS, CABP, PMP – U.S. Department of Veterans Affairs ### 2158956###Program Chair###Supervisor, Transfusion Service Laboratory###U.S. Department of Veterans Affairs###
Program Chair: Phil Accooe, MBA, MS, MLS(ASCP)SBB, CLS, CABP, PMP – U.S. Department of Veterans Affairs
### @@@ Terrie Butler-Foster, MScN (she/her/hers and they/them/theirs) – Canadian Blood Services ### 2118820###Speaker###Manger Stakeholder Relations###Canadian Blood Services###
Speaker: Terrie Butler-Foster, MScN (she/her/hers and they/them/theirs) – Canadian Blood Services
### she/her/hers and they/them/theirs @@@ Avery Belyeu – The Montrose Center ### 2490024###Speaker###Chief Executive Officer###The Montrose Center###
Speaker: Avery Belyeu – The Montrose Center
### @@@ Natalie Vanek, MD (she/her/hers) – Legacy Community Health ### 2503819###Speaker###Clinical Medical Director###Legacy Community Health###
Speaker: Natalie Vanek, MD (she/her/hers) – Legacy Community Health
### she/her/hers @@@ Lou Weaver – MD Anderson Cancer Centre; Lou Weaver Consulting ### 2503966###Speaker###Research Assistant; President/CEO###MD Anderson Cancer Centre; Lou Weaver Consulting###
Speaker: Lou Weaver – MD Anderson Cancer Centre; Lou Weaver Consulting
### AM24-MN-43-L
Transfusion Medicine, Hemostasis, Apheresis, and Cellular Therapy Review Session for Trainees (AM24-SN-26-L)
Favorite

Lance Williams, MD – Mayo Clinic ### 2362124###Speaker###Associate Professor###Mayo Clinic###
Speaker: Lance Williams, MD – Mayo Clinic
### @@@ Huy P. Pham, MD, MPH – NMDP ### 1762665###Program Chair###Medical Director and Adjunct Professor of Medicine###NMDP###
Program Chair: Huy P. Pham, MD, MPH – NMDP
### @@@ Huy P. Pham, MD, MPH – NMDP ### 1762665###Speaker###Medical Director and Adjunct Professor of Medicine###NMDP###
Speaker: Huy P. Pham, MD, MPH – NMDP
### @@@ David Oh, MD, MHA (he/him/his) – Hoxworth Blood Center ### 855747###Speaker###Chief Medical Officer###Hoxworth Blood Center###
Speaker: David Oh, MD, MHA (he/him/his) – Hoxworth Blood Center
### he/him/his AM24-SN-26-L
Transfusion Support for Xenotransplantation (AM24-ST-16-L)
Favorite

Victoria Costa, MD (she/her/hers) – NYU Langone Health ### 2362119###Speaker###Assistant Medical Director###NYU Langone Health###
Speaker: Victoria Costa, MD (she/her/hers) – NYU Langone Health
### she/her/hers @@@ Timothy Hilbert, MD PhD JD – NYU Langone Health ### 2362120###Program Chair###Medical Director###NYU Langone Health###
Program Chair: Timothy Hilbert, MD PhD JD – NYU Langone Health
### @@@ Massimo Mangiola, PhD – NYU Langone Health ### 2362122###Speaker###Immunogenetics Laboratory Director at Transplant Institute###NYU Langone Health###
Speaker: Massimo Mangiola, PhD – NYU Langone Health
### AM24-ST-16-L
Transfusion Threshold Trends in Extremely Low Birthweight Infants (OA5-AM24-MN-07)
Favorite

Jeanne E. Hendrickson, MD – Emory University ### 2038689###Presenting Author###Professor, Department of Pathology and Laboratory Medicine Emory University School of Medicine###Emory University###
Presenting Author: Jeanne E. Hendrickson, MD – Emory University
### OA5-AM24-MN-07
Transfusion Thresholds in Apheresis—Evidence or Art? Current Practice and Interactive Discussion (AM24-SN-18-L)
Favorite

Jensyn Cone Sullivan, MD – Department of Pathology, Michigan Medicine at the University of Michigan ### 2362177###Program Chair###Director, Blood Bank###Department of Pathology, Michigan Medicine at the University of Michigan###
Program Chair: Jensyn Cone Sullivan, MD – Department of Pathology, Michigan Medicine at the University of Michigan
### @@@ Jensyn Cone Sullivan, MD – Department of Pathology, Michigan Medicine at the University of Michigan ### 2362177###Speaker###Director, Blood Bank###Department of Pathology, Michigan Medicine at the University of Michigan###
Speaker: Jensyn Cone Sullivan, MD – Department of Pathology, Michigan Medicine at the University of Michigan
### @@@ Kyle Annen, DO, CABP, QIA (ASCP) (she/her/hers) – Department of Pathology, University of Colorado-Anschutz School of Medicine ### 1765782###Speaker###Medical Director of Apheresis and Cellular Therapy###Department of Pathology, University of Colorado-Anschutz School of Medicine###
Speaker: Kyle Annen, DO, CABP, QIA (ASCP) (she/her/hers) – Department of Pathology, University of Colorado-Anschutz School of Medicine
### she/her/hers @@@ Kyle Annen, DO, CABP, QIA (ASCP) (she/her/hers) – Department of Pathology, University of Colorado-Anschutz School of Medicine ### 1765782###Program Chair###Medical Director of Apheresis and Cellular Therapy###Department of Pathology, University of Colorado-Anschutz School of Medicine###
Program Chair: Kyle Annen, DO, CABP, QIA (ASCP) (she/her/hers) – Department of Pathology, University of Colorado-Anschutz School of Medicine
### she/her/hers AM24-SN-18-L
Transfusion-Associated Circulatory Overload (TACO) Among Inpatient U.S. Medicare Beneficiaries Ages 65 and Older,2016-2023:A Claims-based Study (OA4-AM24-MN-39)
Favorite

Mikhail Menis, PharmD; MS Epi; MS PHSR (he/him/his) – FDA/CBER ### 2118190###Presenting Author###Epidemiologist###FDA/CBER###
Presenting Author: Mikhail Menis, PharmD; MS Epi; MS PHSR (he/him/his) – FDA/CBER
### he/him/his OA4-AM24-MN-39
Treatment-Emergent Antibodies to Amustaline/Glutathione Pathogen-Reduced Red Blood Cells in the ReCePI Phase III Clinical Trial (OA4-AM24-MN-23)
Favorite

Richard Benjamin, MD – Cerus Corporation, Concord, CA, USA ### 2118203###Presenting Author######Cerus Corporation, Concord, CA, USA###
Presenting Author: Richard Benjamin, MD – Cerus Corporation, Concord, CA, USA
### OA4-AM24-MN-23
Turning Over Every Rock: Exploring Advanced Techniques in Platelet and Red Blood Cell Autoantibody Testing (AM24-MN-38-L)

Favorite

Waseem Q. Anani, MD (he/him/his) – University of Utah, ARUP Laboratories ### 2362159###Program Chair###Medical Director###University of Utah, ARUP Laboratories###
Program Chair: Waseem Q. Anani, MD (he/him/his) – University of Utah, ARUP Laboratories
### he/him/his @@@ Marisela G. Marchan, MSTM, MLS(ASCP)SBBcm (she/her/hers) – Versiti ### 837541###Speaker###Manager, Platelet, Neutrophil Immunology Laboratory###Versiti###
Speaker: Marisela G. Marchan, MSTM, MLS(ASCP)SBBcm (she/her/hers) – Versiti
### she/her/hers @@@ Angela Treml, MD – Medical College of Wisconsin, Medical Science institute Versiti ### 1765766###Speaker###Medical Director###Medical College of Wisconsin, Medical Science institute Versiti###
Speaker: Angela Treml, MD – Medical College of Wisconsin, Medical Science institute Versiti
### AM24-MN-38-L
U
Ultimate Test Your Blood Bank Knowledge 2024 (AM24-SN-20-L)
Favorite

Jayanna K. Slayten, MS MLS(ASCP) SBBCM (she/her/hers) – Indiana University Health ### 1762668###Program Chair###Coordinator of Quality and Analytics###Indiana University Health###
Program Chair: Jayanna K. Slayten, MS MLS(ASCP) SBBCM (she/her/hers) – Indiana University Health
### she/her/hers @@@ LeeAnn Walker, MEd, MLS(ASCP)SBB – The University of Texas Medical Branch, Galveston ### 2118013###Speaker###Adjunct Associate Professor###The University of Texas Medical Branch, Galveston###
Speaker: LeeAnn Walker, MEd, MLS(ASCP)SBB – The University of Texas Medical Branch, Galveston
### @@@ Sydney Klausing, MSTM MLS(ASCP)SBB – American Red Cross ### 2410531###Speaker###IRL Technologist III###American Red Cross###
Speaker: Sydney Klausing, MSTM MLS(ASCP)SBB – American Red Cross
### AM24-SN-20-L
Utilizing Sankey Diagrams to Quantify Laboratory Efficiency of INTERCEPT Fibrinogen Complex vs Traditional Cryoprecipitate (OA3-AM24-MN-15)
Favorite

Dennis D. Chen, MPA, MLS(ASCP) (he/him/his) – New York-Presbyterian/Weill Cornell Medical Center ### 2418138###Presenting Author###Transfusion Medicine- Project Leader Information Technology###New York-Presbyterian/Weill Cornell Medical Center###
Presenting Author: Dennis D. Chen, MPA, MLS(ASCP) (he/him/his) – New York-Presbyterian/Weill Cornell Medical Center
### he/him/his OA3-AM24-MN-15
V
Ask the Standards (AM24-ST-23-L)
Favorite

Audra Taylor – South Texas Blood &Tissue ### 2362147###Speaker###Vice President for Blood Operations###South Texas Blood &Tissue###
Speaker: Audra Taylor – South Texas Blood &Tissue
### @@@ Chris Bocquet – AABB ### 2042507###Program Chair###Senior Director, Standards and Quality Initiatives###AABB###
Program Chair: Chris Bocquet – AABB
### @@@ Kate Brown, PhD (she/they) – CooperSurgical, Inc. ### 1762686###Speaker###Senior Director of Science###CooperSurgical, Inc.###
Speaker: Kate Brown, PhD (she/they) – CooperSurgical, Inc.
### she/they AM24-ST-23-L
Validating the BECS (AM24-MN-42-L)
Favorite

Suzanne H. Butch, MA, MLS(ASCP)SBB, DLM (she/her/hers) – Michigan Medicine ### 837452###Program Chair###Clinical Pathology###Michigan Medicine###
Program Chair: Suzanne H. Butch, MA, MLS(ASCP)SBB, DLM (she/her/hers) – Michigan Medicine
### she/her/hers @@@ Suzanne H. Butch, MA, MLS(ASCP)SBB, DLM (she/her/hers) – Michigan Medicine ### 837452###Speaker###Clinical Pathology###Michigan Medicine###
Speaker: Suzanne H. Butch, MA, MLS(ASCP)SBB, DLM (she/her/hers) – Michigan Medicine
### she/her/hers @@@ Stephanie Kinney, MD (she/her/hers) – Cincinnati Children’s Hospital Medical Center ### 833430###Speaker###Medical Director of Clinical Laboratories###Cincinnati Children’s Hospital Medical Center###
Speaker: Stephanie Kinney, MD (she/her/hers) – Cincinnati Children’s Hospital Medical Center
### she/her/hers AM24-MN-42-L
Viral Vector Systems and Cellular Therapy (AM24-SN-19-L)
Favorite

Patrick Conley, MS, CBSP, NREMT (he/him/his) – Merrick and Company ### 2362116###Program Chair###Senior Scientist###Merrick and Company###
Program Chair: Patrick Conley, MS, CBSP, NREMT (he/him/his) – Merrick and Company
### he/him/his @@@ Patrick Conley, MS, CBSP, NREMT (he/him/his) – Merrick and Company ### 2362116###Speaker###Senior Scientist###Merrick and Company###
Speaker: Patrick Conley, MS, CBSP, NREMT (he/him/his) – Merrick and Company
### he/him/his @@@ Anderson Reuben, PE, LEED AP – Merrick ### 2501128###Speaker###Senior Electrical Engineer###Merrick###
Speaker: Anderson Reuben, PE, LEED AP – Merrick
### AM24-SN-19-L
W
What Does the Transfusion Service Need to do to Implement an ABO Incompatible Pediatric Heart Transplant Program? (AM24-SN-03-L)
Favorite

Andrea Pelock, MT(ASCP) – Advocate Christ Medical Center ### 1765692###Program Chair###Transfusion Service Supervisor###Advocate Christ Medical Center###
Program Chair: Andrea Pelock, MT(ASCP) – Advocate Christ Medical Center
### @@@ Kristen Nelson-McMillan, MD (she/her/hers) – Advocate Children's Hospital - Oak Lawn ### 2362171###Speaker###Director, Pediatric MCS, Pulmonary Hypertension; Attending, Advanced Heart Failure, Pediatric Cardiac Critical Care###Advocate Children's Hospital - Oak Lawn###
Speaker: Kristen Nelson-McMillan, MD (she/her/hers) – Advocate Children's Hospital - Oak Lawn
### she/her/hers @@@ Jamie Moore, MLS (ASCP), SBB – Atrium Health ### 2118672###Speaker###Transfusion Services Manager###Atrium Health ###
Speaker: Jamie Moore, MLS (ASCP), SBB – Atrium Health
### AM24-SN-03-L
What is Interventional Transfusion Medicine / Hemotherapy? Why It May Represent a New Future for Transfusion Medicine. (AM24-MN-20-L)
Favorite

Shiu-Ki Hui, MD – Houston Methodist Hospital ### 2118356###Program Chair###Medical Director for Clinical Pathology###Houston Methodist Hospital###
Program Chair: Shiu-Ki Hui, MD – Houston Methodist Hospital
### @@@ Hlaing Tint, MD (he/him/his) – The University of Texas Health Science Center , McGovern Medical School ### 832878###Speaker###Director of Hemotherapy Service###The University of Texas Health Science Center , McGovern Medical School###
Speaker: Hlaing Tint, MD (he/him/his) – The University of Texas Health Science Center , McGovern Medical School
### he/him/his @@@ Lisa Hensch, MD – Department of Pathology, Texas Children's Hospital/Baylor College of Medicine ### 2362166###Speaker###Medical Director of Perioperative Coagulation###Department of Pathology, Texas Children's Hospital/Baylor College of Medicine###
Speaker: Lisa Hensch, MD – Department of Pathology, Texas Children's Hospital/Baylor College of Medicine
### AM24-MN-20-L
What is the Status of the U.S. Blood Supply? Preliminary Findings of the 2023 NBCUS and Latest Trends From Blood Collectors (AM24-MN-22-L)
Favorite

Srijana Rajbhandary, MPH (she/her/hers) – AABB ### 837492###Program Chair###Director###AABB###
Program Chair: Srijana Rajbhandary, MPH (she/her/hers) – AABB
### she/her/hers @@@ Ian T. Kracalik, PhD – Centers for Disease Control and Prevention ### 1792606###Speaker###Epidemiologist###Centers for Disease Control and Prevention###
Speaker: Ian T. Kracalik, PhD – Centers for Disease Control and Prevention
### @@@ Katie Risvold (she/her/hers) – Circulate ### 2435255###Speaker###Executive director###Circulate###
Speaker: Katie Risvold (she/her/hers) – Circulate
### she/her/hers @@@ Hunter Shaffer, MBA – Blood Centers of America (BCA) ### 2117964###Speaker###Sr. Director, Strategic Advisor###Blood Centers of America (BCA)###
Speaker: Hunter Shaffer, MBA – Blood Centers of America (BCA)
### AM24-MN-22-L
Why is My Blood Product Being Quarantined? Investigations that Happen Behind the Scenes (AM24-SN-11-L)
Favorite

Shraddha Patel Babariya, MD (she/her/hers) – American Red Cross ### 1762690###Program Chair###Executive Medical Director, Laboratory Services###American Red Cross###
Program Chair: Shraddha Patel Babariya, MD (she/her/hers) – American Red Cross
### she/her/hers @@@ Saqib Alvi, MD (he/him/his) – American Red Cross- Baltimore, MD ### 2362173###Speaker###Regional Medical Director###American Red Cross- Baltimore, MD###
Speaker: Saqib Alvi, MD (he/him/his) – American Red Cross- Baltimore, MD
### he/him/his @@@ Barry Siegfried, MD – American Red Cross ### 2362174###Speaker###Regional Medical Director###American Red Cross###
Speaker: Barry Siegfried, MD – American Red Cross
### AM24-SN-11-L
Y
Yields in Reiterated Homage to Landsteiner’s Law: Is Binding Blood Banks to ABO Reverse Typing Necessary in Donors with an Established Historical ABO Group? The ABO Reverse Typing (ABORT-Donor) (OA3-AM24-SN-12)
Favorite

Corey W. Dulek, MSTM, MLS(ASCP) – Mayo Clinic ### 2418115###Presenting Author######Mayo Clinic###
Presenting Author: Corey W. Dulek, MSTM, MLS(ASCP) – Mayo Clinic
### OA3-AM24-SN-12